BORGWARNER INC
For the period ended Dec 31, 2025. Filed Feb 11, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 11, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
INTRODUCTION
BorgWarner Inc. and Consolidated Subsidiaries (the “Company” or “BorgWarner”) is a Delaware corporation incorporated in 1987. The Company is a global product leader in clean and efficient technology solutions for combustion, hybrid and electric vehicles. BorgWarner’s products help improve vehicle performance, propulsion efficiency, stability and air quality. The Company manufactures and sells these products worldwide, primarily to original equipment manufacturers (“OEMs”) of light vehicles (passenger cars, sport-utility vehicles, vans and light trucks). The Company's products are also sold to OEMs of commercial vehicles (medium-duty trucks, heavy-duty trucks and buses) and off-highway vehicles (agricultural and construction machinery and marine applications). The Company also manufactures and sells its products to certain tier one vehicle systems suppliers and into the aftermarket for light, commercial and off-highway vehicles. The Company operates manufacturing facilities serving customers in Europe, the Americas and Asia and is an original equipment supplier to nearly every major automotive OEM in the world.
On July 3, 2023, BorgWarner completed the spin-off (“Spin-Off”) of its Fuel Systems and Aftermarket segments in a transaction intended to qualify as tax free to the Company’s stockholders for U.S. federal income tax purposes, which was accomplished by the distribution of 100% of the outstanding common stock of PHINIA, Inc. (“PHINIA”) to holders of record of common stock of the Company on a pro-rata basis.
The historical results of operations of PHINIA for periods prior to the Spin-Off are presented as discontinued operations in these Consolidated Financial Statements.
NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The following paragraphs briefly describe the Company’s significant accounting policies.
Basis of presentation Certain prior period amounts have been reclassified to conform to current period presentation. Additionally, in the year ended December 31, 2024, the Company recognized a $19 million increase in Net earnings attributable to BorgWarner Inc. in the Consolidated Statement of Operations for the correction of misstatements related to certain accruals, of which $12 million related to 2023 (the remainder relates to periods prior to 2023). The Company has evaluated the effect of these out-of-period adjustments for the interim and annual reporting periods in 2024, as well as on the previous interim and annual periods in which they should have been recognized, and concluded that these adjustments are not material to any of the periods affected.
As discussed in the Introduction above, as a result of the Spin-Off, the historical results of operations and the financial position of PHINIA for periods prior to the Spin-Off are presented as discontinued operations in these Consolidated Financial Statements. Refer to Note 26, “Discontinued Operations,” to the Consolidated Financial Statements for more information.
The Company’s Consolidated Financial Statements reflect the results of acquisitions following the date of the respective acquisition. Refer to Note 2, “Acquisitions and Dispositions,” to the Consolidated Financial Statements for more information.
Use of estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the accompanying notes, as well as the amounts of revenues and expenses reported during the periods covered by these financial statements and accompanying notes. Actual results could differ from those estimates.
Principles of consolidation The Consolidated Financial Statements include all majority-owned subsidiaries in which the Company has a controlling financial interest. All inter-company balances and transactions have been eliminated in consolidation.
Change in accounting method Prior to 2024, certain of the Company’s U.S. inventories were accounted for under the last-in, first-out (“LIFO”) method of accounting. During the fourth quarter of 2024, the Company changed the inventory valuation method for those locations from LIFO to the first-in, first-out (“FIFO”) method. FIFO was deemed a preferable method as it better aligns with the accounting practices of the Company’s peers, it more accurately reflects the current value and physical flow of inventory and it harmonizes the accounting method for the majority of inventories across the Company. Retroactive application of the change to prior periods did not have a material impact on any prior periods’ Consolidated Financial Statements, and therefore the Company recognized the cumulative effect of the change in the fourth quarter of 2024 as a reduction in Cost of sales of $29 million in the Consolidated Statements of Operations, which resulted in an increase in income before taxes of $29 million ($22 million after tax) for the three months ended December 31, 2024 with a corresponding increase in Inventories within the Consolidated Balance Sheet as of December 31, 2024.
Joint ventures and equity securities The Company has investments inthree unconsolidated joint ventures, NSK-Warner K.K., Turbo Energy Private Limited and Fast Warner Intelligent Control Systems Co., Ltd. of which the Company owns 50%,32.6% and 49.0%, respectively. These joint ventures are non-controlled affiliates in which the Company exercises significant influence but does not have a controlling financial interest and, therefore, are accounted for under the equity method. Generally, under the equity method, the Company’s original investments in these joint ventures are recorded at cost and subsequently adjusted by the Company’s share of equity in income or losses. The Company monitors its equity method investments for indicators of other-than-temporary declines in fair value on an ongoing basis. If such a decline has occurred, an impairment charge is recorded, which is measured as the difference between the carrying value and the estimated fair value. The Company’s investment in these non-controlled affiliates is included within Investments and long-term receivables in the Consolidated Balance Sheets. The Company’s share of equity in income or losses is included in Equity in affiliates’ earnings, net of tax in the Consolidated Statements of Operations.
The Company also has certain investments for which it does not have the ability to exercise significant influence (generally when ownership interest is less than 20%). The Company’s investment in these equity securities is included within Investments and long-term receivables in the Consolidated Balance Sheet. Refer to Note 10, “Other Current and Non-Current Assets,” to the Consolidated Financial Statements for more information.
Interests in privately held companies that do not have readily determinable fair values are accounted for using the measurement alternative under Accounting Standards Codification (“ASC”) Topic 321, “Investments - Equity Securities,” which includes monitoring on an ongoing basis for indicators of impairments or upward adjustments. These equity securities are measured at cost less impairments, adjusted for observable price changes in orderly transactions for the identical or similar investment of the same issuer. If the Company determines that an indicator of impairment or upward adjustment is present, an adjustment is recorded, which is measured as the difference between carrying value and estimated fair value. Estimated fair value is generally determined using an income approach on discounted cash flows or negotiated transaction values.
Equity securities that have readily determinable fair values are measured at fair value. Equity securities that do not have a readily determinable fair value and which provide a net asset value (“NAV”) or its equivalent, are valued using NAV as a practical expedient. Changes in fair value and NAV are recorded in
Unrealized and realized (gain) loss on equity and debt securities in the Consolidated Statements of Operations.
Debt securities During 2022, the Company invested $500 million in convertible debt securities of Wolfspeed, Inc. (“Wolfspeed”) as part of a strategic partnership with Wolfspeed. The Company elected to classify the debt security as trading and remeasured the investment quarterly using fair value in accordance with ASC Topic 320, “Investments.” In 2023, the investment in Wolfspeed was disposed and the Company recorded a loss in Unrealized and realized (gain) loss on equity and debt securities in the Consolidated Statements of Operations. Prior to the disposition, the changes in fair value were recorded in Unrealized and realized (gain) loss on equity and debt securities in the Consolidated Statements of Operations.
Business combinations In accordance with ASC Topic 805, “Business Combinations,” acquisitions are recorded using the acquisition method of accounting. The Company includes the operating results of acquired entities from their respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date fair value. Various valuation techniques are used to determine the fair value of intangible assets, with the primary techniques being forms of the income approach, specifically the relief-from-royalty and multi-period excess earnings valuation methods. Under these valuation approaches, the Company is required to make estimates and assumptions from a market participant perspective that may include revenue growth rates, estimated earnings, royalty rates, obsolescence factors, contributory asset charges, customer attrition and discount rates. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired, liabilities assumed and any non-controlling interest is recognized as goodwill. Costs incurred as a result of a business combination other than costs related to the issuance of debt or equity securities are recorded in the period the costs are incurred. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to assets acquired and liabilities assumed with the corresponding offset to goodwill.
Revenue recognition Revenue is recognized when performance obligations under the terms of a contract are satisfied, which generally occurs with the transfer of control of the products. For most products, transfer of control occurs upon shipment or delivery; however, a limited number of customer arrangements for highly customized products with no alternative use provide the Company with the right to payment during the production process. As a result, for these limited arrangements, revenue is recognized as goods are produced and control transfers to the customer using the input cost-to-cost method. Revenue is measured at the amount of consideration the Company expects to receive in exchange for transferring the goods. Although the Company may enter into long-term supply arrangements with its major customers, the prices and volumes are not fixed over the life of the arrangements, and a contract does not exist for purposes of applying ASC Topic 606, “Revenue from Contracts with Customers,” until volumes are contractually known.
Sales incentives and allowances (including returns) are recognized as a reduction to revenue at the time of the related sale. The Company estimates the allowances based on an analysis of historical experience. Taxes assessed by a governmental authority collected by the Company concurrent with a specific revenue-producing transaction are excluded from net sales. Shipping and handling fees billed to customers are included in sales, while costs of shipping and handling are included in cost of sales. The Company has elected to apply the accounting policy election available under ASC Topic 606 and accounts for shipping and handling activities as a fulfillment cost.
The Company has a limited number of arrangements with customers where the price paid by the customer is dependent on the volume of product purchased over the term of the arrangement. In other arrangements, the Company will provide a rebate to customers based on the volume of products purchased during the course of the arrangement. The Company estimates the volumes to be sold over the term of the arrangement and recognizes revenue based on the estimated amount of consideration to be received from these arrangements.
The Company continually seeks business development opportunities and at times provides customer incentives for new program awards. The Company evaluates the underlying economics of each amount of consideration payable to a customer to determine the proper accounting by understanding the reasons for the payment, the rights and obligations resulting from the payment, the nature of the promise in the contract, and other relevant facts and circumstances. When the Company determines that the payments are incremental and incurred only if the new business is obtained and expects to recover these amounts from the customer over the term of the new business arrangement, the Company capitalizes these amounts. The Company recognizes a reduction to revenue as products that the upfront payments are related to are transferred to the customer, based on the total amount of products expected to be sold over the term of the arrangement (generally three toseven years). The Company evaluates the amounts capitalized each period end for recoverability and recognizes a reduction to revenue for any amounts that are no longer expected to be recovered over the term of the business arrangement.
Refer to Note 3, “Revenue from Contracts with Customers,” to the Consolidated Financial Statements for more information.
Cost of sales The Company includes materials, direct labor and manufacturing overhead within cost of sales. Manufacturing overhead is comprised of indirect materials, indirect labor, factory operating costs, warranty costs and other such costs associated with manufacturing products for sale.
Cash and cash equivalents Cash and cash equivalents are valued at fair market value. It is the Company's policy to classify all highly liquid investments with original maturities of three months or less as cash and cash equivalents. Cash and cash equivalents are maintained with several financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions of reputable credit and, therefore, bear minimal risk.
Restricted cash Restricted cash includes amounts designated for uses other than current operations and is legally restricted as to use or withdrawal. As of December 31, 2025 and 2024, the Company had no restricted cash.
Receivables, net and long-term receivables Accounts receivable and long-term receivables are stated at cost less an allowance for credit losses. An allowance for credit losses is recorded for amounts that may become uncollectible in the future. The allowance for credit losses is an estimate based on expected losses, current economic and market conditions, and a review of the current status of each customer’s accounts receivable.
Inventories Inventory is measured using FIFO or average-cost methods at the lower of cost or net realizable value.
Pre-production costs related to long-term supply arrangements Engineering, research and development and other design and development costs for products sold on long-term supply arrangements are expensed as incurred unless the Company has a contractual guarantee for reimbursement from the customer. Costs for molds, dies and other tools used to make products sold on long-term supply arrangements for which the Company has title to the assets are capitalized in property, plant and equipment and amortized to cost of sales over the shorter of the term of the arrangement or over the estimated useful lives of the assets, typically three tofive years. Costs for molds, dies and other tools used to make products sold on long-term supply arrangements for which the Company has a contractual guarantee for lump sum reimbursement from the customer are capitalized in prepayments and other current assets.
Property, plant and equipment, net Property, plant and equipment is valued at cost less accumulated depreciation. Expenditures for maintenance, repairs and renewals of relatively minor items are generally charged to expense as incurred. Renewals of significant items are capitalized. Depreciation is generally computed on a straight-line basis over the estimated useful lives of the assets. Useful lives for buildings range from 15 to 40 years, and useful lives for machinery and equipment range from three to 12 years. For income tax purposes, accelerated methods of depreciation are generally used. Refer to Note 11, “Property, Plant and Equipment, Net,” to the Consolidated Financial Statements for more information.
Impairment of long-lived assets, including definite-lived intangible assets The Company reviews the carrying value of its long-lived assets, whether held for use or disposal, including other amortizing intangible assets, when events and circumstances warrant such a review under ASC Topic 360, “Property, Plant and Equipment.” In assessing long-lived assets for an impairment loss, assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. In assessing long-lived assets for impairment, management generally considers individual facilities to be the lowest level for which identifiable cash flows are largely independent. A recoverability review is performed using the undiscounted cash flows if there is a triggering event. If the undiscounted cash flow test for recoverability identifies a possible impairment, management will perform a fair value analysis. Management determines fair value under ASC Topic 820, “Fair Value Measurement,” using the appropriate valuation technique of market, income or cost approach. If the carrying value of a long-lived asset is considered impaired, an impairment charge is recorded for the amount by which the carrying value of the long-lived asset exceeds its fair value. The Company’s impairment loss is calculated based on independent appraisals, discounted cash flows, estimated salvage value, or estimated orderly liquidation value, giving consideration to the highest and best use of the relevant assets.
Management believes that the estimates of future cash flows and fair value assumptions are reasonable; however, changes in assumptions underlying these estimates could affect the valuations. Significant judgments and estimates used by management when evaluating long-lived assets for impairment include (i) an assessment as to whether an adverse event or circumstance has triggered the need for an impairment review; (ii) undiscounted future cash flows generated by the asset; and (iii) fair valuation of the asset.
During the year ended December 31, 2025, the Company recorded impairments of $174 million related to certain property, plant and equipment. The recorded impairments were as follows:
During the year ended December 31, 2025, the Company recorded impairments of property, plant and equipment of $7 million related to the exit of its charging business and the consolidation of the Company’s North American battery systems business footprint within the Battery & Charging Systems reportable segment. The Company estimated fair value using estimated orderly liquidation value based on the Company’s determination of the highest and best use of the relevant assets.
In the fourth quarter of 2025, the Company recorded impairment of property, plant and equipment of $167 million related to customer volume reductionas a result of electric vehicle adoption delays in North America within the PowerDrive Systems reportable segment and dual sourcing actions by certain customers and pricing pressures from competitors within the Battery & Charging Systems reportable segment. The Company estimated fair value using discounted cash flows and estimated orderly liquidation value based on the Company’s determination of the highest and best use of the relevant assets.
During the year ended December 31, 2025, the Company recorded intangible asset impairment assets of $27 million, of which $22 million related to exit of its charging business and the consolidation of the
Company’s North American battery systems business footprint within the Battery & Charging Systems reportable segment. Refer to Note 2, “Acquisitions and Dispositions,” to the Consolidated Financial Statements for more information. Additionally, the Company recorded impairment of $5 million related to intangible assets at PowerDrive Systems.
During the year ended December 31, 2024, the Company recorded impairment charges of $69 million related to certain property, plant and equipment at locations in the Company’s Battery & Charging Systems and PowerDrive Systems reporting segments. In the fourth quarter of 2024, the Company noted deterioration in the forecast of its PowerDrive Systems and Battery & Charging Systems businesses due to further decreases in demand for eProducts as compared to the Company’s expectations as a result of electric vehicle adoption volatility across different regions. This was viewed as a triggering event, and as a result, individual facilities were tested for recoverability. These impairment charges related to locations that failed a recoverability test or where management had initiated plans to liquidate certain assets.
During the year ended December 31, 2023, the Company recorded charges of $29 million, related to the impairment of certain operating lease assets, a customer incentive asset and certain property, plant and equipment.
The charges referenced above were recognized in Impairment charges within the Consolidated Statements of Operations.
In addition, the Company recognized accelerated depreciation charges of$90 million,$50 million and$4 million during the years ended December 31, 2025,2024 and 2023, respectively. These charges related to property, plant and equipment that were decommissioned or were in the process of being decommissioned.
Goodwill and other intangible assets During the fourth quarter of each year, the Company tests goodwill for impairment by either performing a qualitative assessment or a quantitative analysis. In addition, the Company may test goodwill in between annual test dates if an event occurs or circumstances change that could indicate it is more-likely-than-not that the fair value of a reporting unit is below its carrying value.
The qualitative assessment evaluates various events and circumstances, such as macroeconomic conditions, industry and market conditions, cost factors, relevant events and financial trends, that may impact a reporting unit's fair value. Using this qualitative assessment, the Company determines whether it is more-likely-than-not that the reporting unit's fair value exceeds its carrying value. If it is determined that it is not more-likely-than-not the reporting unit's fair value exceeds the carrying value, or upon consideration of other factors, including recent acquisition, restructuring or disposal activity or to refresh the fair values, the Company performs a quantitative goodwill impairment analysis.
The Company has definite-lived intangible assets related to patents and developed technology, customer relationships and trade names. The Company amortizes definite-lived intangible assets over their estimated useful lives. The Company also has intangible assets related to acquired trade names that are classified as indefinite-lived when there are no foreseeable limits on the periods of time over which they are expected to contribute cash flows. Costs to renew or extend the term of acquired intangible assets are recognized as expense as incurred.
Similar to goodwill, the Company can elect to perform the impairment test for indefinite-lived intangibles other than goodwill (primarily trade names) using a qualitative analysis, considering similar factors as outlined in the goodwill discussion, to determine if it is more-likely-than-not that the fair value of the trade names is less than the respective carrying values. If the Company elects to perform or is required to perform a quantitative analysis, the test consists of a comparison of the fair value of the indefinite-lived intangible asset to the carrying value of the asset as of the impairment testing date. The Company estimates the fair value of indefinite-lived intangibles using the relief-from-royalty method, which it believes is an appropriate and widely used valuation technique for such assets. The fair value derived from the relief-from-royalty method is measured as the discounted cash flow savings realized from owning such trade names and not being required to pay a royalty for their use.
During the year ended December 31, 2025, the Company recorded charges of $423 million related to the goodwill at Battery & Charging Systems. Refer to Note 2, “Acquisitions and Dispositions,” and Note 12, “Goodwill and Other Intangibles,” to the Consolidated Financial Statements for more information. During the year ended December 31, 2024, the Company recorded charges of $577 million primarily related to thegoodwill at PowerDrive Systems and Battery & Charging Systems. Refer to Note 12, “Goodwill and Other Intangibles,” to the Consolidated Financial Statements for more information.
These charges were recognized in Impairment charges within the Consolidated Statements of Operations.
Assets and liabilities held for sale The Company classifies assets and liabilities (disposal groups) to be sold as held for sale in the period in which all of the following criteria are met: (1) management, having the authority to approve the action, commits to a plan to sell the disposal group; (2) the disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such disposal groups; (3) an active program to locate a buyer and other actions required to complete the plan to sell the disposal group have been initiated; (4) the sale of the disposal group is probable, and transfer of the disposal group is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond the Company’s control extend the period of time required to sell the disposal group beyond one year; (5) the disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and (6) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.
The Company initially measures a disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Conversely, gains are not recognized on the sale of a disposal group until the date of sale. The Company assesses the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and reports any subsequent changes as an adjustment to the carrying value of the disposal group, as long as the new carrying value does not exceed the carrying value of the disposal group at the time it was initially classified as held for sale. Additionally, depreciation is not recorded during the period in which the long-lived assets, included in the disposal group are classified as held for sale.
Upon determining that a disposal group meets the criteria to be classified as held for sale, the Company reports the assets and liabilities of the disposal group, if material, in the line items assets held for sale and liabilities held for sale in the Consolidated Balance Sheets.
Product warranties The Company provides warranties on some, but not all, of its products. The warranty terms are typically fromone tothree years. Provisions for estimated expenses related to product warranty are made at the time products are sold. These estimates are established using historical information about the nature, frequency and average cost of warranty claim settlements as well as product manufacturing and industry developments and recoveries from third parties. The Company actively studies trends of warranty claims and takes action to improve product quality and minimize warranty claims. Costs of product recalls, which may include the cost of the product being replaced as well as the customer’s cost of the recall, including labor to remove and replace the recalled part, are accrued as part of the Company’s warranty accrual at the time an obligation becomes probable and can be reasonably estimated. The Company believes that the warranty accrual is appropriate; however, actual claims incurred could differ from the original estimates, requiring adjustments to the accrual. The product warranty accrual is allocated to current and non-current liabilities in the Consolidated Balance Sheets.
Refer to Note 13, “Product Warranty,” to the Consolidated Financial Statements for more information.
Other loss accruals and valuation allowances The Company has numerous other loss exposures, such as customer claims, workers’ compensation claims, litigation and recoverability of certain assets. Establishing loss accruals or valuation allowances for these matters requires the use of estimates and judgment in regard to the risk exposure and ultimate realization. The Company estimates losses using consistent and appropriate methods; however, changes to its assumptions could materially affect the recorded accrued liabilities for loss or asset valuation allowances.
Environmental contingencies The Company accounts for environmental costs in accordance with ASC Topic 450, “Contingencies.” Costs related to environmental assessments and remediation efforts at operating facilities are accrued when it is probable that a liability has been incurred and the amount of that liability can be reasonably estimated. Estimated costs are recorded at undiscounted amounts, based on experience and assessments and are regularly evaluated. The liabilities are recorded in Other current and Other non-current liabilities in the Company’s Consolidated Balance Sheets.
Refer to Note 21, “Contingencies,” to the Consolidated Financial Statements for more information.
Government grants The Company periodically receives government grants representing assistance provided by a government. These government grants are generally received in cash and typically provide reimbursement related to acquisition of property and equipment, product development or local governmental economic relief. The government grants are generally amortized using a systematic and rational method over the life of the grant. As of December 31, 2025, the Company recorded government grant related liabilities of $11 million in Other current liabilities and $74 million in Other non-current liabilities in the Company’s Consolidated Balance Sheet. During the year ended December 31, 2025, the Company recorded $46 million and $8 million of government grant-related credits in Selling, general and administrative expenses and Cost of sales, respectively, in the Company’s Consolidated Statement of Operations.
Derivative financial instruments The Company recognizes that certain normal business transactions and foreign currency operations generate risk. Examples of risks include exposure to foreign currency exchange rate risk related to transactions denominated in currencies other than the functional currency, changes in commodity costs and interest rates. It is the objective of the Company to assess the impact of these transaction risks and offer protection from selected risks through various methods, including financial derivatives. Virtually all derivative instruments held by the Company are designated as hedges, have high correlation with the underlying exposure and are highly effective in offsetting underlying price movements. Accordingly, gains and losses from changes in qualifying hedge fair values are matched with the underlying transactions. Hedge instruments are generally reported gross, with no right to offset, on the Consolidated Balance Sheets at their fair value based on quoted market prices for contracts with similar maturities. The Company does not engage in any derivative transactions for purposes other than hedging specific operational risks.
Refer to Note 17, “Financial Instruments,” to the Consolidated Financial Statements for more information.
Foreign currency The financial statements of foreign subsidiaries are translated to U.S. Dollars using the period-end exchange rate for assets and liabilities and an average exchange rate for each period for revenues, expenses and capital expenditures. The local currency is the functional currency for substantially all of the Company's foreign subsidiaries. Translation adjustments for foreign subsidiaries are recorded as a component of accumulated other comprehensive income (loss) in equity. The Company recognizes transaction gains and losses arising from fluctuations in currency exchange rates on transactions denominated in currencies other than the functional currency in earnings as incurred.
Refer to Note 20, “Accumulated Other Comprehensive Loss,” to the Consolidated Financial Statements for more information.
Postretirement defined benefits The Company’s defined benefit pension and other postemployment benefit plans are accounted for in accordance with ASC Topic 715, “Compensation - Retirement Benefits.” Disability, early retirement and other postemployment benefits are accounted for in accordance with ASC Topic 712, “Compensation - Nonretirement Postemployment Benefits.”
Pensions and other postemployment benefit costs and related liabilities and assets are dependent upon assumptions used in calculating such amounts. These assumptions include discount rates, expected returns on plan assets, health care cost trends, compensation and other factors. In accordance with GAAP, actual results that differ from the assumptions used are accumulated and amortized over future periods, and accordingly, generally affect recognized expense in future periods.
Refer to Note 18, “Retirement Benefit Plans,” to the Consolidated Financial Statements for more information.
Restructuring Restructuring costs may occur when the Company takes action to exit or significantly curtail a part of its operations or implements a reorganization that affects the nature and focus of operations. A restructuring charge can consist of severance costs associated with reductions to the workforce, costs to terminate an operating lease or contract, professional fees and other costs incurred related to the implementation of restructuring activities.
The Company generally records costs associated with voluntary separations at the time of employee acceptance. Costs for involuntary separation programs are recorded when management has approved the plan for separation, the employees are identified and aware of the benefits to which they are entitled and it is unlikely that the plan will change significantly. When a plan of separation requires approval by or consultation with the relevant labor organization or government, the costs are recorded upon agreement. Costs associated with benefits that are contingent on the employee continuing to provide service are expensed over the required service period.
Refer to Note 4, “Restructuring,” to the Consolidated Financial Statements for more information.
Income taxes In accordance with ASC Topic 740, “Income Taxes,” the Company’s income tax expense is calculated based on expected income and statutory tax rates in the various jurisdictions in which the Company operates and requires the use of management’s estimates and judgments. Accounting for income taxes is complex, in part because the Company conducts business globally and, therefore, files income tax returns in numerous tax jurisdictions. Management judgment is required in determining the Company’s worldwide provision for income taxes and recording the related assets and liabilities, including accruals for unrecognized tax benefits and assessing the need for valuation allowances.
The determination of accruals for unrecognized tax benefits includes the application of complex tax laws in a multitude of jurisdictions across the Company’s global operations. Management judgment is required in determining the gross unrecognized tax benefits’ related liabilities. In the ordinary course of the Company’s business, there are many transactions and calculations where the ultimate tax determination is less than certain. Accruals for unrecognized tax benefits are established when, despite the belief that tax positions are supportable, there remain certain positions that do not meet the minimum probability threshold, which is a tax position that is more-likely-than-not to be sustained upon examination by the applicable taxing authority.
The Company records valuation allowances to reduce the carrying value of deferred tax assets to amounts that it expects are more-likely-than-not to be realized. The Company assesses existing deferred tax assets, net operating losses and tax credit carryforwards by jurisdiction and expectations of its ability to utilize these tax attributes through a review of past, current and estimated future taxable income and tax planning strategies.
Refer to Note 7, “Income Taxes,” to the Consolidated Financial Statements for more information.
New Accounting Pronouncements
Recently Adopted Accounting Standards
In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Updates (“ASU”) No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” It requires entities to disaggregate information related to the effective tax rate reconciliation and income taxes paid. The standard improves transparency by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. This guidance is effective for annual reporting periods beginning after December 15, 2024. The Company adopted this guidance retrospectively, providing the additional disclosures as required in this report. Refer to Note 7, “Income Taxes” to the Consolidated Financial Statements for more information.
Accounting Standards Not Yet Adopted
In November 2024, the FASB issued ASU No. 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” It requires entities to disclose, in the notes to financial statements, specified information related to certain costs and expenses disaggregated by type. The standard improves transparency by providing more detailed information about the components of costs and expenses that would enable investors to better understand the major components of an entity’s income statement by referencing specific disclosures in the notes to financial statements. This guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. The Company does not expect this guidance to have a material impact on its Consolidated Financial Statements other than the related incremental disclosures.
In July 2025, the FASB issued ASU No. 2025-05, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets.” The standard provides entities with a practical expedient and accounting policy election when estimating expected credit losses on current accounts receivable and current contract assets arising from transactions under FASB Accounting Standards Codification Topic 606, “Revenue From Contracts With Customers”, including assets acquired in a business combinations. This guidance is effective for annual reporting periods beginning after December 15, 2025 including interim reporting periods within those annual reporting periods. The Company intends to apply the practical expedient and does not expect this guidance to have a material impact on its Consolidated Financial Statements.
In September 2025, the FASB issued ASU No. 2025-06, “Intangibles - Goodwill and Other - Internal Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal Use Software.” The standard modernizes and simplifies guidance for internal-use software costs. This guidance is effective for annual reporting periods beginning after December 15, 2027 including interim reporting periods within those annual reporting periods. The Company is evaluating the impact of this guidance on its Consolidated Financial Statements.
In December 2025, the FASB issued ASU No. 2025-10, “Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities.” The standard provides comprehensive recognition, measurement, and presentation guidance for monetary and tangible non-monetary government grants received by business entities. This guidance is effective for annual reporting periods beginning after December 15, 2028 including interim reporting periods within those annual reporting periods. The Company is evaluating the impact of this guidance on its Consolidated Financial Statements.
In December 2025, the FASB issued ASU No. 2025-11, “Interim Reporting (Topic 270): Narrow-Scope Improvements.” The standard clarifies the application of interim reporting guidance and reorganizes existing disclosures. This guidance is effective for interim reporting periods beginning after December 15, 2027. The Company does not expect this guidance to have a material impact on its Consolidated Financial Statements.
NOTE 2 ACQUISITIONS AND DISPOSITIONS
Acquisitions
In accordance with ASC Topic 805, “Business Combinations,” acquisitions are recorded using the acquisition method of accounting. The Company recognizes and measures the acquisition date fair value of the identifiable assets acquired, liabilities assumed, and any non-controlling interest using a range of methodologies as indicated by generally accepted valuation practices. Various valuation techniques are used to determine the fair value of intangible assets, with the primary techniques being forms of the income approach, specifically the relief-from-royalty and multi-period excess earnings valuation methods. Under these valuation approaches, the Company is required to make estimates and assumptions from a market participant perspective and may include revenue growth rates, estimated earnings, royalty rates, obsolescence factors, contributory asset charges, customer attrition and discount rates.
Due to the insignificant size of the Company’s 2023 and 2022 acquisitions, both individually and in the aggregate, relative to the Company, supplemental pro forma financial information for the current and prior reporting periods is not provided.
Hubei Surpass Sun Electric Charging Business
On March 1, 2023, the Company completed its acquisition of 100% of the electric vehicle solution, smart grid and smart energy businesses (“SSE”) of Hubei Surpass Sun Electric, pursuant to an Equity Transfer Agreement. The acquisition was expected to complement the Company’s existing European and North American charging footprint by adding a presence in China. The total consideration was ¥288 million ($42 million), including ¥268 million ($39 million) of base purchase price and ¥19 million ($3 million) of estimated earn-out payments. The Company paid ¥217 million ($31 million) of base purchase price in the year ended December 31, 2023. The Company paid ¥25 million ($4 million) during the year ended December 31, 2024. In accordance with ASC Topic 230, the payments made in 2024 were classified as financing activities in the Company’s Consolidated Statement of Cash Flows, as they occurred more than three months after the acquisition closing date. During the year ended December 31, 2025, the Company recorded a post-closing adjustment of ¥6 million ($1 million) following the review of final closing payment details. The remaining ¥20 million ($3 million) of base purchase price is undergoing negotiations and is payable before March 31, 2026. It was recorded in Other current liabilities in the Company’s Consolidated Balance Sheet as of December 31, 2025 and December 31, 2024. In January 2026, the negotiations were completed, and the Company made the final payment for ¥19 million ($3 million).
Pursuant to the agreement, the Company’s obligation to remit up to ¥103 million ($15 million) of earn-out payments is contingent upon the achievement of certain revenue and pre-tax profit margin targets in 2023 and 2024, as well as the retention of key employees during the same time period. During the year ended December 31, 2024, the Company paid ¥10 million ($1 million) of earn-out related amounts. During the year ended December 31, 2025, the Company paid the remaining earn-out of approximately ¥10 million ($2 million).
As described further below, in February 2025, the Company made the decision to exit its charging business within the Battery & Charging Systems reportable segment, which included SSE.
Drivetek AG
On December 1, 2022, the Company completed its acquisition of 100% of Drivetek AG (“Drivetek”), an engineering and product development company located in Switzerland. This acquisition strengthened the Company’s power electronics capabilities in auxiliary inverters, which has helped to accelerate the growth of the Company’s High Voltage eFan business. The total consideration was ₣37 million ($39 million), including ₣27 million ($29 million) of base purchase price and ₣10 million ($10 million) of estimated earn-out payments. The Company paid ₣27 million ($29 million) of base purchase price at closing. The Company’s obligation to remit up to ₣10 million ($10 million) of earn-out payments, over thethree years following closing, is contingent upon achievement of estimated future sales targets associated with newly awarded business and future turnover rate targets. During the year ended December 31, 2025, the Company paid ₣2 million ($2 million) of earn-out-related amounts. As of December 31, 2025, the Company’s estimate of the earn-out payments was approximately ₣2 million ($3 million), which was recorded in Other current liabilities in the Company’s Consolidated Balance Sheet.
Dispositions
Exit of Charging Business
In February 2025, the Company decided to exit its charging business within the Battery & Charging Systems reportable segment. This decision was made following the Company’s continuing evaluation of its product portfolio and future investments. Production operations ceased during the second quarter of 2025.
The majority of the charging business related to the SSE business, which was marketed for sale and met the criteria to be reported as held-for-sale as of March 31, 2025. The SSE business sale closed in the second quarter of 2025 with proceeds totaling approximately $7 million. During the year ended December 31, 2025, the Company recorded charges of $22 million related to the loss on the sale of the SSE business. The other locations within the charging business ceased operations during the second quarter of 2025 and did not meet the criteria to be reported as held-for-sale. The Company’s exit of its charging business did not meet the criteria for presentation as a discontinued operation.
During the year ended December 31, 2025, the Company recorded charges of $32 million related to the exit of its charging business within the Battery & Charging Systems reportable segment. These charges primarily relate to a $22 million loss on the sale of the SSE business during the year ended December 31, 2025 which was recorded in Other operating expense, net, and the write-off of $9 million of inventory during the year ended December 31, 2025, which was recorded in Cost of sales in the Consolidated Statements of Operations. In addition, the Company recorded charges totaling $39 million during the year ended December 31, 2025, which included impairments of intangible assets, goodwill and fixed assets of $22 million, $13 million and $4 million, respectively. Refer to Note 12, “Goodwill and Other Intangibles,” to the Consolidated Financial Statements for more information.
PHINIA, Inc.
On July 3, 2023, BorgWarner completed the spin-off (“Spin-Off”) of its Fuel Systems and Aftermarket segments in a transaction intended to qualify as tax free to the Company’s stockholders for U.S. federal income tax purposes, which was accomplished by the distribution of 100% of the outstanding common stock of PHINIA, Inc. (“PHINIA”) to holders of record of common stock of the Company on a pro-rata basis.
The historical results of operations of PHINIA for periods prior to the Spin-Off are presented as discontinued operations in these Consolidated Financial Statements.
In connection with the Spin-Off, the Company entered into several agreements with PHINIA on or prior to the Distribution Date that, among other things, provide a framework for the Company’s relationship with PHINIA after the Spin-Off, including a separation and distribution agreement, an employee matters agreement, a tax matters agreement, an intellectual property cross-license agreement and a transition services agreement through which the Company and PHINIA continued to provide certain services to each other following the Spin-Off. In December 2024, the Company and PHINIA executed an amendment to the original transition services agreement to extend certain engineering services until September 30, 2025. The transition services agreement expired and all related services ended on September 30, 2025. On October 15, 2025, the Company entered into a settlement agreement with PHINIA, and in connection with the settlement agreement, the Company and PHINIA also entered into an amended and restated tax matters agreement that, among other things, limits the Company’s responsibility to certain defined tax obligations.
Refer to Note 21, “Contingencies” and Note 26, “Discontinued Operations” to the Consolidated Financial Statements for more information.
NOTE 3 REVENUE FROM CONTRACTS WITH CUSTOMERS
The Company manufactures and sells products, primarily to OEMs of light vehicles and, to a lesser extent, to OEMs of commercial vehicles and off-highway vehicles, to certain tier one vehicle systems suppliers and into the aftermarket. The Company’s payment terms are based on customary business practices and vary by customer type and products offered. The Company has evaluated the terms of its arrangements and determined that they do not contain significant financing components.
Generally, revenue is recognized upon shipment or delivery; however, a limited number of the Company’s customer arrangements for its highly customized products with no alternative use provide the Company with the right to payment during the production process. As a result, for these limited arrangements, revenue is recognized as goods are produced and control transfers to the customer using the input cost-to-cost method. The Company recorded a contract asset of $15 million December 31, 2025 and 2024, for these arrangements. These amounts are reflected in Prepayments and other current assets in the Company’s Consolidated Balance Sheets.
In limited instances, certain customers have provided payments in advance of receiving related products, typically at the onset of an arrangement prior to the beginning of production. These contract liabilities are reflected as Other current liabilities and Other non-current liabilities in the Consolidated Balance Sheets. As of December 31, 2025, Other current liabilities and Other non-current liabilities were $1 million, respectively. As of December 31, 2024, Other current liabilities and Other non-current liabilities were $13 million and $29 million, respectively. These amounts are reflected as revenue over the term of the arrangement (typically three toseven years) as the underlying products are shipped and represent the Company’s remaining performance obligations as of the end of the period.
The Company continually seeks business development opportunities and at times provides customer incentives for new program awards. When the Company determines that the payments are incremental and incurred only if the new business is obtained and expects to recover these amounts from the customer over the term of the new business arrangement, the Company capitalizes these amounts. As of December 31, 2025 and 2024, the Company recorded customer incentive payments of $7 million and $22 million, respectively, in Prepayments and other current assets, and $22 million and $23 million, respectively, in Other non-current assets in the Consolidated Balance Sheets. The Company evaluates the amounts capitalized each period end for recoverability and writes off any amounts that are no longer expected to be recovered over the term of the business arrangement. During the year ended December 31, 2025 , the Company wrote off a $7 million customer incentive asset, which was recorded in Net sales in the Company’s Consolidated Statements of Operations.
The Company’s products can be disaggregated by two types: eProducts and Foundational products. eProducts include all products utilized on or for electric vehicles (“EVs”) plus those same products and components that are included in hybrid powertrains whose underlying technologies are adaptable or applicable to those used in or for EVs. Foundational products include all products utilized on internal combustion engines plus those same products and components that are also included in hybrid powertrains. The following table represents a disaggregation of revenue from contracts with customers by Foundational products and eProducts for the years ended December 31, 2025, 2024, and 2023.
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| Foundational products | $11,746 | $11,751 | $12,161 |
| eProducts | 2,570 | 2,335 | 2,037 |
| Total | $14,316 | $14,086 | $14,198 |
The following table represents a disaggregation of revenue from contracts with customers by reportable segment and region for the years ended December 31, 2025, 2024, and 2023. Refer to Note 24,
“Reportable Segments and Related Information” of the Consolidated Financial Statements for additional details.
| Year ended December 31, 2025 | |||||
|---|---|---|---|---|---|
| (in millions) | Turbos & Thermal Technologies | Drivetrain & Morse Systems | PowerDrive Systems | Battery & Charging Systems | Total |
| North America | $1,403 | $2,088 | $341 | $202 | $4,034 |
| Europe | 2,844 | 1,252 | 683 | 369 | 5,148 |
| Asia | 1,263 | 2,295 | 1,298 | 2 | 4,858 |
| Other | 259 | — | — | 17 | 276 |
| Total | $5,769 | $5,635 | $2,322 | $590 | $14,316 |
| Year ended December 31, 2024 | |||||
|---|---|---|---|---|---|
| (in millions) | Turbos & Thermal Technologies | Drivetrain & Morse Systems | PowerDrive Systems | Battery & Charging Systems | Total |
| North America | $1,432 | $1,943 | $310 | $199 | $3,884 |
| Europe | 2,941 | 1,273 | 548 | 484 | 5,246 |
| Asia | 1,304 | 2,348 | 1,050 | 17 | 4,719 |
| Other | 208 | — | — | 29 | 237 |
| Total | $5,885 | $5,564 | $1,908 | $729 | $14,086 |
| Year ended December 31, 2023 | |||||
|---|---|---|---|---|---|
| (in millions) | Turbos & Thermal Technologies | Drivetrain & Morse Systems | PowerDrive Systems | Battery & Charging Systems | Total |
| North America | $1,529 | $1,972 | $458 | $134 | $4,093 |
| Europe | 3,026 | 1,299 | 372 | 384 | 5,081 |
| Asia | 1,250 | 2,272 | 1,268 | 20 | 4,810 |
| Other | 202 | — | 4 | 8 | 214 |
| Total | $6,007 | $5,543 | $2,102 | $546 | $14,198 |
NOTE 4 RESTRUCTURING
The Company’s undertakes restructuring activities, as necessary, to execute management’s strategy and streamline operations, consolidate and take advantage of available capacity and resources and ultimately achieve net cost reductions. Restructuring activities include efforts to integrate and rationalize the Company’s business and to relocate operations to best-cost locations.
The Company’s restructuring expenses consist primarily of employee termination benefits (principally severance and/or other termination benefits) and other costs, which are primarily professional fees and costs related to facility closures and exits.
The following table represents restructuring expenses by reportable segment for the years ended December 31, 2025, 2024, and 2023. Refer to Note 24, “Reportable Segments and Related Information” of the Consolidated Financial Statements for additional details.
| (in millions) | Turbos & Thermal Technologies | Drivetrain & Morse Systems | PowerDrive Systems | Battery & Charging Systems | Corporate | Total |
|---|---|---|---|---|---|---|
| Employee termination benefits | $44 | $(1) | $19 | $11 | $5 | $78 |
| Other | 5 | 2 | 12 | 4 | — | 23 |
| Total restructuring expense | $49 | $1 | $31 | $15 | $5 | $101 |
| Employee termination benefits | $21 | $10 | $10 | $1 | $1 | $43 |
| Other | 18 | 1 | 12 | — | — | 31 |
| Total restructuring expense | $39 | $11 | $22 | $1 | $1 | $74 |
| Employee termination benefits | $63 | $6 | $1 | $— | $— | $70 |
| Other | 7 | 2 | — | — | — | 9 |
| Total restructuring expense | $70 | $8 | $1 | $— | $— | $79 |
The following table displays a roll forward of the restructuring liability recorded within the Company’s Consolidated Balance Sheets and the related cash flow activity:
| (in millions) | Employee termination benefits | Other | Total |
|---|---|---|---|
| Balance at January 1, 2025 | $39 | $5 | $44 |
| Restructuring expense, net | 78 | 23 | 101 |
| Cash payments | (76) | (16) | (92) |
| Foreign currency translation adjustment and other | 1 | — | 1 |
| Balance at December 31, 2025 | $42 | $12 | $54 |
| Less: Non-current restructuring liability | 6 | — | 6 |
| Current restructuring liability at December 31, 2025 | $36 | $12 | $48 |
2024 Structural Costs Plan In June 2024, the Company approved an approximately $75 million restructuring plan to address the cost structure in its PowerDrive Systems segment due to electric vehicle adoption volatility across different regions, which could include realignment of the segment’s manufacturing footprint. During the years ended December 31, 2025 and 2024, the Company recorded $31 million and $13 million, respectively, of restructuring costs related to this plan. Cumulatively, the Company has incurred $44 million of restructuring charges related to this plan.
2023 Structural Costs Plan In 2023, the Company announced a $130 million to $150 million restructuring plan to address structural costs in its Foundational products businesses. During the years ended December 31, 2025, 2024 and 2023, the Company recorded $8 million, $61 million and $79 million, respectively, of restructuring costs related to this plan. Cumulatively, the Company has incurred $148 million of restructuring costs related to this plan. The actions under this plan are complete.
During the year ended December 31, 2025, the Company recorded $62 million of restructuring costs for individually approved restructuring actions, as more fully described below.
There have been no changes in previously initiated plans that have resulted (or are expected to result) in a material change to the Company’s restructuring costs.
The following provides details of restructuring expense incurred by the Company’s reportable segments during the years ended December 31, 2025, 2024 and 2023, related to the plans discussed above:
Turbos & Thermal Technologies
During the year ended December 31, 2025, the segment recorded $7 million of restructuring costs under this plan. These costs primarily related to $5 million of employee termination benefits and $2 million of professional fees for facilities in Europe and China.
During the year ended December 31, 2024, the segment recorded $39 million of restructuring costs under this plan. These costs primarily related to $21 million of employee termination benefits and $18 million of professional fees and equipment relocation costs for facilities in Europe and China and U.S.
During the year ended December 31, 2023, the segment recorded $70 million of restructuring costs under this plan. These costs primarily related to employee termination benefits associated with the announced closure of a facility in Europe affecting approximately 200 employees.
Other Actions
During the year ended December 31, 2025, the Company recorded $42 million of restructuring costs for individually approved restructuring actions. These costs primarily related to $39 million of employee termination benefits and $3 million of contractual settlement expense for facilities in Europe and China.
Drivetrain & Morse Systems
During the year ended December 31, 2024, the segment recorded $11 million of restructuring costs under this plan. These costs primarily related to $10 million of employee termination benefits for facilities in Europe and the U.S.
During the year ended December 31, 2023, the segment recorded $8 million of restructuring costs under this plan. These costs primarily related to $6 million of employee termination benefits and $2 million of equipment moves.
PowerDrive Systems
2024 Structural Costs Plan
During the year ended December 31, 2025, the segment recorded $31 million of restructuring costs under this plan. These costs primarily related to $19 million of employee termination benefits and $12 million of equipment relocation costs for facilities in the U.S., Mexico, Asia and Europe.
During the year ended December 31, 2024, the segment recorded $13 million of restructuring costs under this plan. These costs primarily related to $9 million of employee termination benefits and $4 million of professional fees.
During the year ended December 31, 2024, the segment recorded $9 million of restructuring costs under this plan. These costs primarily related to $8 million of equipment relocation costs.
Battery & Charging Systems
During the year ended December 31, 2025, the segment recorded $15 million of individually approved restructuring costs. These costs primarily related to $11 million of employee termination benefits and $4 million of contract cancellations and professional fees for facilities in the U.S and China, including the consolidation of the Company’s North American battery systems business footprint and the exit of its charging business. Refer to Note 2, “Acquisitions and Dispositions,” for more information.
Corporate
During the year ended December 31, 2025, $5 million of individually approved restructuring costs were recorded. These costs primarily related to employee termination benefits associated with a global overhead cost reduction initiative.
Estimates of restructuring expense are based on information available at the time such charges are recorded. Due to the inherent uncertainty involved in estimating restructuring expenses, actual amounts paid for such activities may differ from amounts initially recorded. Accordingly, the Company may record revisions of previous estimates by adjusting previously established accruals.
The Company continues to evaluate different options across its operations to reduce existing structural costs over the next few years. The Company will recognize restructuring expense associated with any future actions at the time they are approved and become probable or are incurred. Any future actions could result in significant restructuring expense.
NOTE 5 RESEARCH AND DEVELOPMENT COSTS
The Company’s net Research & Development (“R&D”) expenditures are primarily included in Selling, general and administrative expenses of the Consolidated Statements of Operations. Customer reimbursements are netted against gross R&D expenditures as they are considered a recovery of cost. Customer reimbursements for prototypes are recorded net of prototype costs based on customer contracts, typically either when the prototype is shipped or when it is accepted by the customer. Customer reimbursements for engineering services are recorded when performance obligations are satisfied in accordance with the contract. Financial risks and rewards transfer upon shipment, acceptance of a prototype component by the customer or upon completion of the performance obligation as stated in the respective customer agreement. The Company has various customer arrangements relating to R&D activities that it performs at its various R&D locations.
The following table presents the Company’s gross and net expenditures on R&D activities:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| Gross R&D expenditures | $823 | $872 | $856 |
| Customer reimbursements | (113) | (136) | (139) |
| Net R&D expenditures | $710 | $736 | $717 |
Net R&D expenditures as a percentage of net sales were 5.0%,5.2% and 5.1% for the years ended December 31, 2025, 2024 and 2023, respectively.
NOTE 6 OTHER OPERATING EXPENSE (INCOME), NET
Items included in Other operating expense (income), net consist of:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| Legal settlement | $40 | $— | $— |
| Costs to exit charging business | 23 | — | — |
| Impairment of investment | 16 | — | — |
| Chief Executive Officer ("CEO") transition compensation | 11 | — | — |
| Loss (gain) on sale of assets | 9 | 2 | (13) |
| Adjustments associated with Spin-Off related balances | 7 | 17 | — |
| Merger and acquisition expense, net | 5 | 2 | 23 |
| Loss (gain) on sale of businesses | 2 | 6 | (5) |
| Commercial contract settlement | — | 15 | — |
| Spin-Off transition services income, net | — | (5) | (10) |
| Other income, net | (4) | (5) | (11) |
| Other operating expense (income), net | $109 | $32 | $(16) |
Legal settlement: During the year ended December 31, 2025, the Company recorded a charge of $40 million, related to a legal settlement, inclusive of associated legal fees. Refer to Note 21, “Contingencies,” to the Consolidated Financial Statements for more information.
Costs to exit charging business: During the year ended December 31, 2025, the Company recorded charges of $23 million related to the exit of its charging business within the Battery & Charging Systems reportable segment. Refer to Note 2, “Acquisitions and Dispositions,” and Note 12, “Goodwill and Other Intangibles,” to the Consolidated Financial Statements for more information.
Impairment of investment: During the year ended December 31, 2025, the Company recorded a charge of $16 million related to the impairment of an investment without a readily determinable fair value.
Chief Executive Officer ("CEO") transition compensation: During the year ended December 31, 2025, the Company recorded charges of $11 million related to duplicative compensation.
Loss (gain) on sale of assets: During the year ended December 31, 2025, the Company recorded a loss of $9 million related to the sale of equipment from a closed facility in North America and the sale of a building in Europe. During the year ended December 31, 2024, the Company recorded a $2 million loss on sale of fixed assets at a European manufacturing facility. During the year ended December 31, 2023, the Company recorded a $13 million gain on sale of fixed assets, primarily attributed to the sale of a European manufacturing facility and other fixed assets.
Adjustments associated with Spin-Off related balances: During the year ended December 31, 2025, the Company recorded expense of $7 million primarily for adjustments related to the contract manufacturing agreement with PHINIA and adjustments to net amounts owed to the Company related to the tax matters agreement between the Company and PHINIA, unrelated to the legal settlement discussed above. During the year ended December 31, 2024, the Company recorded expense of $17 million, primarily for adjustments to net amounts owed to the Company related to the tax matters agreement between the Company and PHINIA.
Merger and acquisition expense, net: During the year ended December 31, 2025, the Company recorded merger and acquisition expense, net of $5 million, primarily related to professional fees associated with specific acquisition initiatives. During the year ended December 31, 2024, the Company recorded a merger and acquisition expense, net of $2 million, primarily related to professional fees associated with specific acquisition initiatives, mostly offset by a gain of $6 million related to the revision of its expected earn-out related to the Drivetek acquisition. During the year ended December 31, 2023, the Company recorded merger and acquisition expense, net of $23 million, primarily related to professional fees for specific acquisition initiatives. This merger and acquisition expense, net included an $8 million loss related to a change in estimate of the expected earn-out estimate associated with the Santroll acquisition.
Loss (gain) on sale of businesses: During the year ended December 31, 2025, the Company recorded a net loss of $2 million related to a business closure in North America, plant disposal in China and the sale of an operation in Europe. During the year ended December 31, 2024, the Company recorded a net loss on sale of business of $6 million primarily related to the estimated loss on an immaterial business that met held for sale accounting criteria. During the year ended December 31, 2023, the Company recorded a net gain on sale of business in North America of $5 million.
Commercial contract settlement: During the year ended December 31, 2024, the Company recorded a loss of approximately $15 million related to the settlement of a commercial contract assumed in its acquisition of the electric hybrid systems business segment of Eldor Corporation.
Spin-Off transition services income, net: During the year ended December 31, 2024 and 2023, the Company recorded other income in the amount of $5 million and $10 million, respectively, for net service reimbursements related to the Spin-Off. These transition services were related to information technology, human resources, finance, facilities, procurement, sales, intellectual property and engineering. Refer to Note 26, “Discontinued Operations,” to the Consolidated Financial Statements for more information.
NOTE 7 INCOME TAXES
Earnings before income taxes and the provision for income taxes are presented in the following table.
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| Earnings (loss) before income taxes: | |||
| U.S.1 | $(177) | $(303) | $(316) |
| Non-U.S. | 701 | 842 | 1,307 |
| Total | $524 | $539 | $991 |
| Provision for income taxes: | |||
| Current: | |||
| Federal2 | $(1) | $(18) | $(1) |
| State | (3) | 1 | 8 |
| Foreign2 | 326 | 284 | 342 |
| Total current expense | 322 | 267 | 349 |
| Deferred: | |||
| Federal | (76) | (198) | (85) |
| State | (7) | (5) | — |
| Foreign | (50) | 47 | 25 |
| Total deferred benefit | (133) | (156) | (60) |
| Total provision for income taxes | $189 | $111 | $289 |
1 In 2023, the U.S. loss before income taxes included the realized and unrealized loss on debt and equity securities of $174 million that was primarily related to the Company’s investment in Wolfspeed convertible debt securities that was sold during the year.
2 In accordance with ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which requires withholding tax expense to be reflected in the jurisdiction in which the tax is imposed, the Company reclassified $45 million and $43 million of withholding tax expense for 2024 and 2023, respectively, from U.S. current tax expense to foreign current tax expense.
The reconciliation of the tax provision at the U.S. federal statutory rate to income tax expense is presented in the following table.
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| (in millions) · 2025 · 2024 · 2023 | ||||||
| U.S. federal statutory tax rate | $110 | 21.0% | $114 | 21.0% | $209 | 21.0% |
| State and local income taxes1 | (10) | (1.9) | — | — | 6 | 0.6 |
| Enactment of new tax laws | — | — | (9) | (1.7) | — | — |
| Effect of cross-border tax laws | ||||||
| Foreign-derived intangible income | — | — | (11) | (2.0) | (23) | (2.3) |
| Global intangible low-taxed income | 36 | 6.9 | 24 | 4.5 | 19 | 1.9 |
| Net tax on remittance of foreign earnings | 1 | 0.2 | (17) | (3.2) | (10) | (1.0) |
| Other | 14 | 2.7 | 1 | 0.2 | 11 | 1.1 |
| Tax credits | ||||||
| Foreign tax credits | (48) | (9.2) | (47) | (8.7) | (40) | (4.0) |
| Research and development credit | (10) | (1.9) | (26) | (4.8) | (34) | (3.4) |
| Changes in valuation allowances | (6) | (1.1) | 32 | 5.9 | 39 | 3.9 |
| Nontaxable or nondeductible items | ||||||
| Intercompany transaction gain | (6) | (1.1) | (15) | (2.8) | (61) | (6.1) |
| Other | 14 | 2.7 | 9 | 1.7 | 5 | 0.5 |
| Other adjustments | ||||||
| Realization of basis differences | (40) | (7.6) | (13) | (2.4) | 1 | 0.1 |
|---|---|---|---|---|---|---|
| Other | 2 | 0.4 | 13 | 2.4 | (6) | (0.6) |
| Foreign tax effects | ||||||
| China | ||||||
| Effect of rates different than statutory | 21 | 4.0 | 4 | 0.7 | 18 | 1.8 |
| Withholding tax | 37 | 7.1 | 33 | 6.1 | 52 | 5.2 |
| Net tax on remittance of foreign earnings | (6) | (1.1) | (6) | (1.1) | (21) | (2.1) |
| Impairment of goodwill | — | — | 94 | 17.5 | (1) | (0.1) |
| Tax holiday | (39) | (7.4) | (45) | (8.4) | (35) | (3.5) |
| Enhanced research and development deduction | (24) | (4.6) | (29) | (5.4) | (35) | (3.5) |
| Changes in valuation allowances | 18 | 3.4 | — | — | — | — |
| Other | (7) | (1.3) | 8 | 1.5 | (6) | (0.6) |
| Germany | ||||||
| Effect of rates different than statutory | 28 | 5.3 | (7) | (1.3) | 1 | 0.1 |
| Impairment of goodwill | 61 | 11.4 | 32 | 6.1 | — | — |
| State and local income taxes | (5) | (1.0) | 14 | 2.6 | 2 | 0.2 |
| Other | 27 | 5.2 | (16) | (3.0) | 20 | 2.0 |
| Italy | ||||||
| Changes in valuation allowances | (2) | (0.4) | 14 | 2.6 | — | — |
| Other | 7 | 1.3 | 6 | 1.1 | 7 | 0.7 |
| Korea | ||||||
| Withholding tax | 13 | 2.5 | 14 | 2.6 | 13 | 1.3 |
| Impairment of goodwill | — | — | 18 | 3.3 | — | — |
| Other | 8 | 1.5 | (6) | (1.1) | 6 | 0.6 |
| Mexico | ||||||
| Intercompany transaction gain | — | — | — | — | (16) | (1.6) |
| Other | 15 | 2.9 | (5) | (0.9) | 19 | 1.9 |
| France | ||||||
| Changes in valuation allowances | 1 | 0.2 | (2) | (0.4) | 96 | 9.7 |
| Other | 1 | 0.2 | — | — | (6) | (0.6) |
| Luxembourg | ||||||
| Changes in valuation allowances | — | — | — | — | 37 | 3.7 |
| Other | (3) | (0.6) | 3 | 0.6 | (3) | (0.3) |
| Other foreign jurisdictions | 1 | 0.2 | 31 | 5.8 | 31 | 3.1 |
| Changes in unrecognized tax benefits | (20) | (3.8) | (99) | (18.4) | (6) | (0.6) |
| Income tax expense | $189 | 36.1% | $111 | 20.6% | $289 | 29.1% |
1 State taxes in Mississippi (2025), Illinois and Kentucky (2024 & 2023) comprise the majority (greater than 50%) of the tax effect in that category.
The Company’s tax rate is affected by the tax laws and rates of the U.S. and other jurisdictions in which the Company operates, the relative amount of income earned by jurisdiction and the relative amount of losses or income for which no tax benefit or expense was recognized due to a valuation allowance.
In 2025, the Company reflected a $126 million tax impact of non-deductible impairment of goodwill. In addition, the Company recorded a tax benefit of $29 million related to reductions in certain unrecognized tax benefits and accrued interest for positions remeasured after various audit closures, a tax benefit of $16 million related to the exit of the charging business and a tax benefit of $7 million related to tax law changes.
In 2024, the Company reflected a $151 million tax impact of non-deductible impairment of goodwill. In addition, the Company recorded a tax benefit of $107 million related to reductions in certain unrecognized tax benefits and accrued interest for matters where the statute of limitations lapsed and a tax benefit of $36 million related to post Spin-Off restructuring.
In 2023, the Company recognized a tax benefit of $19 million related to the resolution of tax audits and reductions in certain unrecognized tax benefits and accrued interest related to matters for which the statute of limitation had lapsed. In addition, the Company recognized a tax benefit of $50 million in relation to the Spin-Off, a tax benefit of $30 million in relation to various changes in filling positions for prior years, and a tax expense of $79 million in relation to changes in judgment related to the recovery of deferred tax assets, primarily due to the impact of the Spin-Off on the allocation of the Company’s profits across jurisdictions for tax purposes as well as various tax structuring actions and strategies.
A roll forward of the Company’s total gross unrecognized tax benefits is presented below:
| (in millions) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Balance, January 1 | $95 | $161 | $172 |
| Additions based on tax positions related to current year | 7 | 9 | 15 |
| Reductions for closure of tax audits and settlements | (1) | — | (5) |
| Reductions for tax positions of prior years | (37) | (1) | (11) |
| Reductions for lapse in statute of limitations | — | (67) | (10) |
| Translation adjustment | 9 | (7) | — |
| Balance, December 31 | $73 | $95 | $161 |
The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense and accrued approximately $28 million and $22 million for the payment of interest and penalties at December 31, 2025 and 2024, respectively. For the years ended December 31, 2025, 2024 and 2023, the Company recognized expense related to interest and penalties of $4 million, $5 million and $10 million, respectively. During the year ended December 31, 2024, the Company also recorded a reduction in tax expense of $46 million for previously recorded interest related to matters for which the statute of limitations lapsed.
As of December 31, 2025, approximately $80 million represents the amount that, if recognized, would affect the Company's effective income tax rate in future periods. This amount includes a decrease in U.S. federal income taxes that would occur upon recognition of the state tax benefits and U.S. foreign tax credits included therein.
The Company and/or one of its subsidiaries files income tax returns with the U.S. federal and various state and foreign jurisdictions. In certain tax jurisdictions, the Company may have more than one taxpayer. The Company is no longer subject to income tax examinations by tax authorities in its major tax jurisdictions as follows:
| Tax jurisdiction | Years no longer subject to audit | Tax jurisdiction | Years no longer subject to audit |
|---|---|---|---|
| U.S. Federal | 2021 and prior | Luxembourg | 2020 and prior |
| China | 2019 and prior | Mexico | 2019 and prior |
| France | 2021 and prior | Poland | 2019 and prior |
| Germany | 2018 and prior | South Korea | 2019 and prior |
| Hungary | 2019 and prior | United Kingdom | 2021 and prior |
| Japan | 2023 and prior | ||
The components of deferred tax assets and liabilities consist of the following:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Deferred tax assets: | ||
| Net operating loss and capital loss carryforwards | $320 | $305 |
| Research and development capitalization | 332 | 291 |
| Employee compensation | 77 | 45 |
| Other comprehensive loss | 28 | — |
| Warranty | 33 | 30 |
| Tax credits | 106 | 67 |
| Other | 86 | 116 |
| Total deferred tax assets | $982 | $854 |
| Valuation allowance | (360) | (325) |
| Net deferred tax asset | $622 | $529 |
| Deferred tax liabilities: | ||
| Goodwill and intangible assets | (88) | (100) |
| Unremitted foreign earnings | (88) | (95) |
| Fixed assets | (55) | (107) |
| Other comprehensive gain | — | (35) |
| Total deferred tax liabilities | $(231) | $(337) |
| Net deferred taxes | $391 | $192 |
As of December 31, 2025, the Company had non-U.S. net operating loss (“NOL”) deferred tax assets of $235 million, $26 million of which expire at various dates from 2026 through 2045 and $209 million of which have an indefinite life. As of December 31, 2025, the Company had a valuation allowance of $201 million with regards to these deferred tax assets. As of December 31, 2025, certain non-U.S. subsidiaries have tax credit carryforwards of $21 million of which expire at various dates from 2026 to 2035. As of December 31, 2025, the Company had a valuation allowance of $2 million with regards to these deferred tax assets.
As of December 31, 2025, U.S. subsidiaries had net operating loss (“NOL”) deferred tax assets of approximately $39 million, of which $15 million expire at various dates from 2026 through 2044 and $24 million of which have an indefinite life. As of December 31, 2025, the Company had a valuation allowance of $36 million with regard to these deferred tax assets. As of December 31, 2025, certain U.S. subsidiaries have tax credit carryforwards of $85 million of which expire at various dates from 2026 to 2045. As of December 31, 2025, the Company had a valuation allowance of $47 million with regard to these deferred tax assets.
On a quarterly basis, the Company reviews the likelihood that the benefit of its deferred tax assets will be realized and, therefore, the need for valuation allowances. The Company assesses existing deferred tax assets, net operating loss carryforwards and tax credit carryforwards by jurisdiction and expectations of its ability to utilize these tax attributes through a review of past, current, and estimated future taxable income and tax planning strategies. If, based upon the weight of available evidence, it is more-likely-than-not the deferred tax assets will not be realized, a valuation allowance is recorded. Due to recent restructurings, the Company concluded that the weight of the negative evidence outweighs the positive evidence in certain foreign jurisdictions. As a result, the Company believes it is more-likely-than-not that the net deferred tax assets in certain jurisdictions that include entities in France, Spain, U.S., Italy, Turkey, Germany, and China will not be realized in the future.
As of December 31, 2025, the Company recorded deferred tax liabilities of $88 million with respect to foreign unremitted earnings. The Company did not provide deferred tax liabilities with respect to certain book versus tax basis differences not represented by undistributed earnings. The Company’s best estimate of the unrecognized deferred tax liability on these basis differences is approximately $4 million as of December 31, 2025.
Cash paid for income taxes, net of refunds is presented in the following table:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| U.S. state | $1 | $10 | $7 |
| U.S. federal | — | 50 | 47 |
| Total foreign | 371 | 346 | 308 |
| China | 105 | 96 | 91 |
| Korea | 42 | 47 | 41 |
| Poland | 35 | 20 | 30 |
| Spain | 33 | 32 | 30 |
| Mexico | 31 | 46 | 20 |
| Germany | 23 | 6 | 23 |
| India | 23 | 18 | 15 |
| Other foreign | 79 | 81 | 58 |
| Total | $372 | $406 | $362 |
NOTE 8 RECEIVABLES, NET
The table below provides details of receivables as of December 31, 2025 and 2024:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Receivables, net: | ||
| Customers | $2,407 | $2,273 |
| Indirect taxes | 329 | 310 |
| Other | 248 | 281 |
| Gross receivables | 2,984 | 2,864 |
| Allowance for credit losses | (22) | (21) |
| Total receivables, net | $2,962 | $2,843 |
The table below summarizes the activity in the allowance for credit losses for the years ended December 31, 2025, 2024 and 2023:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| Beginning balance, January 1 | $(21) | $(12) | $(11) |
| Provision | (7) | (10) | (4) |
| Write-offs | 8 | — | 2 |
| Translation adjustment and other | (2) | 1 | 1 |
| Ending balance, December 31 | $(22) | $(21) | $(12) |
NOTE 9 INVENTORIES
A summary of Inventories is presented below:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Raw material and supplies | $888 | $915 |
| Work-in-progress | 157 | 147 |
| Finished goods | 162 | 189 |
| Inventories | $1,207 | $1,251 |
NOTE 10 OTHER CURRENT AND NON-CURRENT ASSETS
Additional detail related to assets is presented below:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Prepayments and other current assets: | ||
| Prepaid tooling | $109 | $107 |
| Prepaid taxes | 105 | 98 |
| Derivative instruments | 18 | 19 |
| Contract assets (Note 3) | 15 | 15 |
| Prepaid insurance | 11 | 11 |
| Other | 55 | 83 |
| Total prepayments and other current assets | $313 | $333 |
| Investments and long-term receivables: | ||
| Investment in equity affiliates | $251 | $245 |
| Investment in equity securities | 59 | 70 |
| Long-term receivables | 47 | 41 |
| Total investments and long-term receivables | $357 | $356 |
| Other non-current assets: | ||
| Deferred income taxes (Note 7) | $556 | $359 |
| Operating leases (Note 22) | 151 | 177 |
| Derivative instruments | 27 | 89 |
| Customer incentive payments (Note 3) | 22 | 23 |
| Other | 82 | 62 |
| Total other non-current assets | $838 | $710 |
NOTE 11 PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment, net is stated at cost less accumulated depreciation and amortization, and consisted of:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Land, land use rights and buildings | $1,373 | $1,354 |
| Machinery and equipment | 5,844 | 5,520 |
| Finance lease assets | 28 | 30 |
| Construction in progress | 407 | 437 |
| Total property, plant and equipment, gross | 7,652 | 7,341 |
| Less: accumulated depreciation | 4,557 | 4,007 |
| Property, plant and equipment, net, excluding tooling | 3,095 | 3,334 |
| Tooling, net of amortization | 235 | 241 |
| Property, plant and equipment, net | $3,330 | $3,575 |
Interest costs capitalized for the years ended December 31, 2025, 2024 and 2023 were $11 million, $15 million and $17 million, respectively.
NOTE 12 GOODWILL AND OTHER INTANGIBLES
Goodwill is the excess of the purchase price over the estimated fair value of identifiable net assets acquired in business combinations. As of December 31, 2025, the Company hadfour reportable segments andfour goodwill reporting units.
2025 Goodwill Analyses
During the first quarter of 2025, as a result of the Company’s plan to exit the charging business, the Company separately allocated the goodwill from its historical reporting unit of Battery & Charging Systems to the battery systems business and to the charging business on a relative fair value basis. The Company estimated the allocated fair values of the businesses from the historical reporting unit based upon the present value of their anticipated future cash flows. The estimated fair value of the charging business was determined using a cost approach. The Company’s determination of fair value involved judgment and the use of estimates and assumptions. During the first quarter of 2025, the relative fair value analysis resulted in an allocation, and subsequent impairment, of $13 million related to the goodwill allocated to the charging business. Refer to Note 2, “Acquisitions and Dispositions,” to the Consolidated Financial Statements for more information.
In conjunction with the goodwill allocation in the first quarter of 2025, the Company performed a quantitative impairment assessment of the Battery & Charging Systems’ goodwill after the impairment of the charging business’ goodwill. Based on this interim impairment test, the Battery & Charging Systems reporting unit had an estimated fair value that exceeded its carrying value, including goodwill, by approximately 18%, resulting in no impairment at that time.
During the fourth quarter of 2025, the Company performed a qualitative analysis on its Turbos & Thermal Technologies and Drivetrain & Morse Systems reporting units and performed a quantitative analysis on its Battery & Charging Systems reporting unit. The goodwill associated with the Company’s PowerDrive Systems reporting unit was fully impaired during the year ended December 31, 2024. The Company’s qualitative assessment on its Turbos & Thermal Technologies and Drivetrain & Morse Systems reporting units indicated it was more-likely-than-not the fair value of these reporting units exceeded the carrying value.
For the quantitative analysis of the Battery & Charging Systems reporting unit, the estimated fair values were determined using an income approach. Under the income approach, fair value is determined based on present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate.
The Company believes the assumptions and estimates used to determine the estimated fair value are reasonable. Different assumptions could materially affect the estimated fair value. The significant assumptions affecting the Company’s 2025 goodwill quantitative impairment review were as follows:
Discount rates: The Company used a 14% weighted average cost of capital (“WACC”) as the discount rates for future cash flows. The WACC is intended to represent a rate of return that would be expected by a market participant.
Operating income (loss) margin: The Company used historical and expected operating income (loss) margins, which may vary based on the projection of the reporting unit being evaluated.
Revenue growth rates: The Company used a global automotive market industry growth rate forecast adjusted to estimate its own market participation for product lines.
In addition to the above significant assumptions, the Company noted the following risks to volume and operating income assumptions that could have an impact on the discounted cash flow models:
The automotive industry is cyclical, and the Company’s results of operations could be adversely affected by industry downturns.
The automotive industry is evolving, and if the Company does not respond appropriately, its results of operations could be adversely affected.
The Company is dependent on market segments that use its key products and could be affected by decreasing demand in those segments.
The Company is subject to risks related to international operations.
During the fourth quarter of 2025, in connection with the preparation of the Company’s annual financial statements, the Company noted deterioration in the forecast for its Battery & Charging Systems business. This deterioration was due to dual sourcing actions by certain customers and electric vehicle adoption delays in North America. As a result, during the fourth quarter of 2025, the Company recorded an incremental impairment charge of $410 million. For the year ended December 31, 2025, the Company recorded total goodwill impairment charges of $423 million related to the Battery & Charging Systems reporting unit.
The goodwill impairment charges related to Battery & Charging Systems represent the difference between carrying value and fair value, meaning the carrying value for this reporting unit now approximates its fair value. The fair value of the Battery & Charging Systems reporting unit’s goodwill is sensitive to differences between estimated and actual cash flows, including changes in the projected revenue, projected operating margin and discount rate used to evaluate the fair value of these assets and market multiples assumptions applied by the Company.
2024 Goodwill Analyses
During the first quarter of 2024, the Company reduced the outlook of its PowerDrive Systems business in response to volatility in actual and expected customer production schedules. This was viewed as a triggering event, and as a result, the Company performed an interim quantitative analysis of the fair value of the PowerDrive Systems reporting unit. Based on this interim impairment test, the PowerDrive Systems reporting unit had an estimated fair value that exceeded its carrying value, including goodwill, by approximately 5%, resulting in no impairment, at that time.
During the third quarter of 2024, as a result of the previously disclosed reportable segment realignment, the Company disaggregated certain entities within one of the Company’s historical goodwill reporting units acrosstwo reporting units: Drivetrain & Morse Systems and Battery & Charging Systems. As a result of this change, the Company allocated goodwill to thesetwo reporting units on a relative fair value basis. The Company estimated the fair values of the businesses to be split from the historical reporting unit based upon the present value of their anticipated future cash flows. The Company’s determination of fair value involved judgment and the use of estimates and assumptions. In conjunction with the goodwill allocation, the Company performed a quantitative impairment assessment of the historical reporting units’ goodwill immediately before and after the segment realignment. The quantitative analyses did not result in any impairment charges as the fair value of each reporting unit exceeded its respective carrying value.
During the fourth quarter of 2024, the Company performed a qualitative analysis ontwo of the reporting units and performed a quantitative analysis on the othertwo reporting units. For the quantitative analyses, the estimated fair values were determined using an income and market approach. The market approach is based on market multiples (revenue and “EBITDA”, defined as earnings before interest, taxes, depreciation and amortization) and requires an estimate of appropriate multiples based on market data for comparable companies. The market valuation models and other financial ratios used by the Company require certain assumptions and estimates regarding the applicability of those models to the Company’s facts and circumstances.
During the fourth quarter of 2024, in connection with the preparation of the Company’s annual financial statements, the Company noted deterioration in the forecast for its PowerDrive Systems and Battery & Charging Systems businesses. This deterioration was due to further decreases in demand for eProducts as compared to the Company’s expectations as a result of electric vehicle adoption volatility across different regions. This downward revision to the outlooks of these businesses was due to volatility in actual and expected customer production schedules. The Company had made capital investments to support new eProducts business that has been delayed and/or launched with lower-than-expected volumes. As a result, during the fourth quarter of 2024, the Company recorded goodwill impairment charges of $468 million and $109 million related to the PowerDrive Systems and Battery & Charging Systems reporting units, respectively.
With respect to the quantitative analyses performed during the years ended December 31, 2025, 2024 and 2023, future changes in the judgments, assumptions and estimates from those used in acquisition-related valuations and goodwill impairment testing, including discount rates or future operating results and related cash flow projections, could result in significantly different estimates of the fair values in the future. An increase in discount rates, a reduction in projected cash flows or a combination of the two could lead to a reduction in the estimated fair values, which may result in impairment charges that could materially affect the Company’s financial statements in any given year.
A summary of the changes in the carrying amount of goodwill is presented in the following tables. Refer to Note 24, “Reportable Segments and Related Information” for more information.
| 2025 | |||||
|---|---|---|---|---|---|
| (in millions) | Turbos & Thermal Technologies | Drivetrain & Morse Systems | PowerDrive Systems | Battery & Charging Systems | Total |
| Gross goodwill balance, January 1 | $1,235 | $1,120 | $468 | $613 | $3,436 |
| Accumulated impairment losses, January 1 | (502) | — | (468) | (109) | (1,079) |
| Net goodwill balance, January 1 | $733 | $1,120 | $— | $504 | $2,357 |
| Goodwill during the year: | |||||
| Impairment | — | — | — | (423) | (423) |
| Other, primarily translation adjustment | 44 | 12 | — | 65 | 121 |
| Net goodwill balance, December 31 | $777 | $1,132 | $— | $146 | $2,055 |
| Gross goodwill balance, December 31 | $1,279 | $1,132 | $468 | $678 | $3,557 |
| Accumulated impairment losses, December 31 | (502) | — | (468) | (532) | (1,502) |
| Net goodwill balance, December 31 | $777 | $1,132 | $— | $146 | $2,055 |
| 2024 | |||||
|---|---|---|---|---|---|
| (in millions) | Turbos & Thermal Technologies | Drivetrain & Morse Systems | PowerDrive Systems | Battery & Charging Systems | Total |
| Gross goodwill balance, January 1 | $1,257 | $1,126 | $481 | $651 | $3,515 |
| Accumulated impairment losses, January 1 | (502) | — | — | — | (502) |
| Net goodwill balance, January 1 | $755 | $1,126 | $481 | $651 | $3,013 |
| Goodwill during the year: | |||||
| Impairment | — | — | (468) | (109) | (577) |
| Measurement period adjustments1 | — | — | 6 | — | 6 |
| Other, primarily translation adjustment | (22) | (6) | (19) | (38) | (85) |
| Net goodwill balance, December 31 | $733 | $1,120 | $— | $504 | $2,357 |
| Gross goodwill balance, December 31 | $1,235 | $1,120 | $468 | $613 | $3,436 |
| Accumulated impairment losses, December 31 | (502) | — | (468) | (109) | (1,079) |
| Net goodwill balance, December 31 | $733 | $1,120 | $— | $504 | $2,357 |
1 Measurement period adjustments relate to the Company’s 2023 purchase of Eldor Corporation.
The Company’s other intangible assets, primarily from acquisitions, consist of the following:
| December 31, 2025 · December 31, 2024 | |||||||
|---|---|---|---|---|---|---|---|
| (in millions) | Estimated useful lives (years) | Gross carrying amount | Accumulated amortization | Net carrying amount | Gross carrying amount | Accumulated amortization | Net carrying amount |
| Amortized intangible assets: | |||||||
| Patented and unpatented technology | 5 - 15 | $338 | $210 | $128 | $352 | $172 | $180 |
| Customer relationships | 6 - 15 | 639 | 379 | 260 | 610 | 321 | 289 |
| Miscellaneous | 2 - 5 | 10 | 8 | 2 | 9 | 7 | 2 |
| Total amortized intangible assets | 987 | 597 | 390 | 971 | 500 | 471 | |
| Unamortized trade names | 4 | — | 4 | 3 | — | 3 | |
| Total other intangible assets | $991 | $597 | $394 | $974 | $500 | $474 | |
Amortization of other intangible assets was $66 million, $69 million and $67 million for the years ended December 31, 2025, 2024 and 2023, respectively. The Company utilizes the straight-line method of amortization recognized over the estimated useful lives of the assets. The estimated future annual amortization expense, primarily for acquired intangible assets, is as follows: $57 million in 2026, $49 million in 2027, $49 million in 2028, $50 million in 2029, $48 million in 2030 and $137 million thereafter.
A roll forward of the gross carrying amounts and related accumulated amortization of the Company’s other intangible assets is presented below:
| Gross carrying amounts | Accumulated amortization | |||
|---|---|---|---|---|
| (in millions) | 2025 | 2024 | 2025 | 2024 |
| Beginning balance, January 1 | $974 | $1,020 | $500 | $456 |
| Measurement period adjustments1 | — | (4) | — | — |
| Impairment / write-offs | (36) | (3) | (9) | — |
| Amortization | — | — | 66 | 69 |
| Translation adjustment | 53 | (39) | 40 | (25) |
| Ending balance, December 31 | $991 | $974 | $597 | $500 |
1 Measurement period adjustments relate to the Company’s 2023 purchase of Eldor Corporation.
NOTE 13 PRODUCT WARRANTY
The following table summarizes the activity in the product warranty accrual accounts:
| (in millions) | 2025 | 2024 |
|---|---|---|
| Beginning balance, January 1 | $215 | $196 |
| Provisions for current period sales | 108 | 85 |
| Adjustments of prior estimates | 1 | 15 |
| Payments | (86) | (71) |
| Other, primarily translation adjustment | 16 | (10) |
| Ending balance, December 31 | $254 | $215 |
The product warranty liability is classified in the Consolidated Balance Sheets as follows:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Other current liabilities | $86 | $88 |
| Other non-current liabilities | 168 | 127 |
| Total product warranty liability | $254 | $215 |
During the year ended December 31, 2025, the Company recognized and collected an insurance recovery of $21 million related to a resolved historical warranty matter as a reduction of Cost of sales in the Consolidated Statements of Operations.
NOTE 14 DEBT
The Company had debt outstanding as follows:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Short-term borrowings | $3 | $61 |
| Long-term debt | ||
| 3.375% Senior notes due 03/15/25 | — | 334 |
| 2.650% Senior notes due 07/01/27 ($1,100 million par value) | 1,097 | 1,095 |
| 7.125% Senior notes due 02/15/29 ($121 million par value) | 120 | 120 |
| 4.950% Senior notes due 08/15/29 ($500 million par value) | 496 | 495 |
| 1.000% Senior notes due 05/19/31 (€1,000 million par value) | 1,163 | 1,022 |
| 5.400% Senior notes due 08/15/34 ($500 million par value) | 494 | 493 |
| 4.375% Senior notes due 03/15/45 ($500 million par value) | 495 | 495 |
| Term loan facilities, finance leases and other | 31 | 46 |
| Total long-term debt | 3,896 | 4,100 |
| Less: current portion | 2 | 337 |
| Long-term debt, net of current portion | $3,894 | $3,763 |
On March 15, 2025, the Company’s 3.375% senior notes matured and were repaid in accordance with the terms of the indenture.
In August 2024, the Company announced that it had commenced tender offers to purchase for cash certain of the Company’s outstanding 3.375% senior notes due in March 2025 (the “March 2025 Senior
Notes”) and the 5.000% senior notes due in October 2025 (the “October 2025 Senior Notes”). Pursuant to the tender offers, the Company purchased and extinguished $50 million of the March 2025 Senior Notes and $110 million of the October 2025 Senior Notes. On November 1, 2024, the Company redeemed the remaining $343 million outstanding October 2025 Senior Notes at a make-whole redemption price of 101 percent. The tender offers and redemption resulted in a net gain on debt extinguishment of $10 million, primarily related to the write-off of the remaining unamortized fair value up to the October 2025 Senior Notes. The net gain on debt extinguishment is recorded to Interest expense, net, in the Consolidated Statements of Operations.
In September 2023, the Company purchased and extinguished $438 million of senior notes due in 2025, comprised of $115 million and $323 million face value of its March 2025 and October 2025 Senior Notes, respectively. Total cash consideration paid was $430 million. The Company recorded a gain of approximately $28 million during the year ended December 31, 2023, consisting of an $8 million gain related to a cash settlement below the face value of the 2025 notes and $20 million related to the write-off of a portion of the unamortized fair value step up on the October 2025 Senior Notes from the Delphi Technologies acquisition in 2020 and a portion of the unamortized discount on the March 2025 Senior Notes due in 2025 that was recorded at the time of that note issuance. The gain on extinguishment was recorded to Interest expense, net, in the Consolidated Statement of Operations.
The Company may utilize uncommitted lines of credit for short-term working capital requirements. As of December 31, 2025 and 2024, the Company had $3 million and $61 million, respectively, in borrowings under these facilities, which are classified in Short-term debt in the Consolidated Balance Sheets. The short-term borrowings as of December 31, 2024, primarily relate to a European money market loan with an interest rate of Euribor plus 1.75% that is callable upon immediate notice by either party.
The weighted average interest rate on short-term borrowings outstanding as of December 31, 2025 and 2024 was 0.7% and 4.0%, respectively. The weighted average interest rate on all borrowings outstanding, including the effects of outstanding swaps, as of December 31, 2025 and 2024 was 2.5% and 2.8%, respectively. The following table provides details on Interest expense, net included in the Consolidated Statements of Operations. Interest expense primarily relates to interest on the Company’s fixed rate Senior notes, net of any amortization of premium or discount. Interest income primarily relates to interest received on cash and investments and interest received on the Company’s net investment hedges.
The following table provides details on Interest expense, net included in the Consolidated Statement of Operations:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| Interest expense | $99 | $84 | $73 |
| Interest income | (60) | (54) | (35) |
| Gain on debt extinguishment | — | (10) | (28) |
| Interest expense, net | $39 | $20 | $10 |
Annual principal payments required as of December 31, 2025 are as follows:
| (in millions) | |
|---|---|
| 2026 | $5 |
| 2027 | 1,106 |
| 2028 | 5 |
| 2029 | 633 |
| 2030 | 2 |
| After 2030 | 2,179 |
| Total payments | $3,930 |
| Less: unamortized premiums, net of discount | (31) |
| Total short and long-term debt | $3,899 |
The Company’s long-term debt includes various covenants, none of which are expected to restrict future operations.
The Company has a $2 billion multi-currency revolving credit facility that allows the Company to increase the facility by $1 billion with bank group approval. This facility matures in September 2028. The credit agreement contains customary events of default and one key financial covenant, which is a debt-to-EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) ratio. The Company was in compliance with the financial covenant at December 31, 2025. At December 31, 2025 and 2024, the Company hadno outstanding borrowings under this facility.
The Company’s commercial paper program allows the Company to issue up to $2 billion of short-term, unsecured commercial paper notes under the limits of its multi-currency revolving credit facility. Under this program, the Company may issue notes from time to time and use the proceeds for general corporate purposes. The Company hadno outstanding borrowings under this program as of December 31, 2025 and 2024.
The total current combined borrowing capacity under the multi-currency revolving credit facility and commercial paper program cannot exceed $2 billion.
As of December 31, 2025 and 2024, the estimated fair values of the Company’s senior unsecured notes totaled $3,690 million and $3,797 million, respectively. The estimated fair values were $175 million and $257 million lower than carrying value at December 31, 2025 and 2024, respectively. Fair market values of the senior unsecured notes are developed using observable values for similar debt instruments, which are considered Level 2 inputs as defined by ASC Topic 820. The carrying values of the Company’s multi-currency revolving credit facility, commercial paper program and other debt facilities approximate fair value. The fair value estimates do not necessarily reflect the values the Company could realize in the current markets.
The Company had outstanding letters of credit of $36 million and $29 million at December 31, 2025 and 2024, respectively. The letters of credit typically act as guarantees of payment to certain third parties in accordance with specified terms and conditions.
NOTE 15 OTHER CURRENT AND NON-CURRENT LIABILITIES
Additional detail related to liabilities is presented in the table below:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Other current liabilities: | ||
| Payroll and employee related | $380 | $361 |
| Customer-related | 236 | 173 |
| Income taxes payable | 113 | 115 |
| Product warranties (Note 13) | 86 | 88 |
| Indirect taxes | 77 | 117 |
| Operating leases (Note 22) | 36 | 38 |
| Employee termination benefits (Note 4) | 36 | 31 |
| Accrued freight | 36 | 22 |
| Supplier related | 29 | 26 |
| Interest | 27 | 31 |
| Insurance | 17 | 18 |
| Derivative instruments | 16 | 27 |
| Retirement related (Note 18) | 14 | 10 |
| Other non-income taxes | 12 | 12 |
| Deferred engineering | 12 | 10 |
| Other restructuring (Note 4) | 12 | 5 |
| Government grants | 11 | 22 |
| Other | 131 | 110 |
| Total other current liabilities | $1,281 | $1,216 |
| Other non-current liabilities: | ||
| Product warranties (Note 13) | $168 | $127 |
| Deferred income taxes (Note 7) | 165 | 167 |
| Operating leases (Note 22) | 122 | 144 |
| Other income tax liabilities | 101 | 118 |
| Derivative instruments | 97 | 5 |
| Deferred income | 84 | 88 |
| Other | 114 | 92 |
| Total other non-current liabilities | $851 | $741 |
NOTE 16 FAIR VALUE MEASUREMENTS
ASC Topic 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC Topic 820 establishes a fair value hierarchy, which prioritizes the inputs used in measuring fair values as follows:
Level 1: Observable inputs such as quoted prices for identical assets or liabilities in active markets;
Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques noted in ASC Topic 820:
A. Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business.
B. Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost).
C. Income approach: Techniques to convert future amounts to a single present amount based upon market expectations (including present value techniques, option-pricing and excess earnings models).
Fair Value Measurements on a Recurring Basis
The following tables classify assets and liabilities measured at fair value on a recurring basis as of December 31, 2025 and 2024:
| Basis of fair value measurements | ||||||
|---|---|---|---|---|---|---|
| Balance at December 31, 2025 | Quoted prices in active markets for identical items (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Valuation technique | Assets measured at NAV1 | |
| (in millions) | ||||||
| Assets: | ||||||
| Investment in equity securities | $28 | $— | $— | $— | — | $28 |
| Foreign currency contracts | $22 | $— | $22 | $— | A | $— |
| Net investment hedge contracts | $23 | $— | $23 | $— | A | $— |
| Liabilities: | ||||||
| Current earn-out liabilities | $3 | $— | $— | $3 | C | $— |
| Foreign currency contracts | $19 | $— | $19 | $— | A | $— |
| Net investment hedge contracts | $94 | $— | $94 | $— | A | $— |
| Basis of fair value measurements | ||||||
|---|---|---|---|---|---|---|
| (in millions) | Balance at December 31, 2024 | Quoted prices in active markets for identical items (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Valuation technique | Assets measured at NAV1 |
| Assets: | ||||||
| Investment in equity securities | $25 | $— | $— | $— | — | $25 |
| Foreign currency contracts | $24 | $— | $24 | $— | A | $— |
| Net investment hedge contracts | $84 | $— | $84 | $— | A | $— |
| Liabilities: | ||||||
| Current earn-out liabilities | $4 | $— | $— | $4 | C | $— |
| Non-current earn-out liabilities | $3 | $— | $— | $3 | C | $— |
| Foreign currency contracts | $32 | $— | $32 | $— | A | $— |
1 Certain assets that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. These amounts represent investments in commingled and managed funds that have underlying assets in fixed income securities, equity securities, and other assets and the fair values have been estimated using the net asset value of the Company's ownership interest in partners' capital. The Company’s redemption of its investments with the funds is governed by the partnership agreements and subject to approval from the general partners. With the exception of annual distributions in connection with the Company’s deemed tax liability, distributions from each fund will be received as the underlying investments of the funds are liquidated, the timing of which is unknown.
The following tables provide a reconciliation of the Company’s Level 3 earn-out assets and liabilities:
| Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | ||
|---|---|---|
| (in millions) | Current earn-out liabilities | Non-current earn-out liabilities |
| Balance at January 1, 2025 | $4 | $3 |
| Reclassification | 3 | (3) |
| Earn-out settlements | (4) | — |
| Balance at December 31, 2025 | $3 | $— |
Refer to Note 2, “Acquisitions and Dispositions,” to the Consolidated Financial Statements for more detail regarding earn-outs.
The following tables provide a reconciliation of the Company’s defined benefit plans assets measured at fair value on a recurring basis:
| Basis of fair value measurements | ||||||
|---|---|---|---|---|---|---|
| (in millions) | Balance at December 31, 2025 | Quoted prices in active markets for identical items (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Valuation technique | Assets measured at NAV2 |
| U.S. Plans: | ||||||
| Fixed income securities | $77 | $— | $— | $— | — | $77 |
| Equity securities | 4 | — | — | — | — | 4 |
| Alternative credit fund | 15 | — | — | — | — | 15 |
| Cash | 29 | 29 | — | — | A | — |
| $125 | $29 | $— | $— | $96 | ||
| Non-U.S. Plans: | ||||||
| Fixed income securities | $144 | $26 | $— | $— | A | $118 |
| Equity securities | 90 | 72 | — | — | A | 18 |
| Cash | 1 | 1 | — | — | A | — |
| Insurance contract1 | 131 | — | — | 131 | C | — |
| Real estate and other | 66 | 37 | 12 | — | A,C | 17 |
| $432 | $136 | $12 | $131 | $153 | ||
| Basis of fair value measurements | ||||||
|---|---|---|---|---|---|---|
| (in millions) | Balance at December 31, 2024 | Quoted prices in active markets for identical items (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Valuation technique | Assets measured at NAV2 |
| U.S. Plans: | ||||||
| Fixed income securities | $76 | $— | $— | $— | — | $76 |
| Equity securities | 16 | — | — | — | — | 16 |
| Alternative credit fund | 15 | — | — | — | — | 15 |
| Cash | 19 | 19 | — | — | A | — |
| $126 | $19 | $— | $— | $107 | ||
| Non-U.S. Plans: | ||||||
| Fixed income securities | $141 | $23 | $— | $— | A | $118 |
| Equity securities | 73 | 60 | — | — | A | 13 |
| Cash | 33 | 33 | — | — | A | — |
| Insurance contract1 | 98 | — | — | 98 | C | — |
| Real estate and other | 35 | 5 | 13 | — | A,C | 17 |
| $380 | $121 | $13 | $98 | $148 | ||
1 A BorgWarner defined benefit plan in the United Kingdom owns an insurance contract that guarantees payment of specified pension liabilities. The Company measures the fair value of the insurance asset by projecting expected future cash flows from the contract and discounting them to present value based on current market rates, including an assessment for non-performance risk of the insurance company. The assumptions used to project expected future cash flows are based on actuarial estimates and are unobservable; therefore, the contract is categorized within Level 3 of the hierarchy.
2 Certain assets that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. These amounts represent investments in commingled and managed funds that have underlying assets in fixed income securities, equity securities, and other assets.
The following tables provide a reconciliation of the Company’s Level 3 defined benefit plans assets:
| Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | |
|---|---|
| (in millions) | Insurance contract |
| Balance at January 1, 2025 | $98 |
| Purchases, sales and settlements | 33 |
| Benefits paid | (8) |
| Translation adjustment | 8 |
| Balance at December 31, 2025 | $131 |
Refer to Note 18, “Retirement Benefit Plans,” to the Consolidated Financial Statements for more detail surrounding the defined benefit plan’s asset investment policies and strategies, target allocation percentages and expected return on plan asset assumptions.
Fair Value Measurements on a Nonrecurring Basis
The Company measures certain assets at fair value on a nonrecurring basis. These fair value measurements are classified within Level 3 of the fair value hierarchy.
During the year ended December 31, 2025, the Company recorded asset impairment charges of$174 million related to certain property, plant, and equipment at locations in the Company’s Battery & Charging Systems and PowerDrive Systems reporting segments. During the year ended December 31, 2024, the Company recorded asset impairment charges of$69 million related to certain property, plant, and equipment at locations in the Company’s Battery & Charging Systems and PowerDrive Systems reporting segments. Refer to Note 1, “Summary of Significant Accounting Policies,” to the Consolidated Financial Statements for more information.
During the year ended December 31, 2025, the Company recorded investment impairment charges of $16 million. Refer to Note 6, “Other Operating Expense (Income), Net,”to the Consolidated Financial Statements for more information.
NOTE 17 FINANCIAL INSTRUMENTS
The Company’s financial instruments include cash and cash equivalents, marketable securities and accounts receivable. Due to the short-term nature of these instruments, their book value approximates their fair value. The Company’s financial instruments may include long-term debt, investments in equity securities, interest rate and cross-currency swaps, commodity derivative contracts and foreign currency derivative contracts. All derivative contracts are placed with counterparties that have an S&P, or equivalent, investment grade credit rating at the time of the contracts’ placement. An adjustment for non-performance risk is considered in the estimate of fair value in derivative assets based on the counterparty credit default swap (“CDS”) rate. When the Company is in a net derivative liability position, the non-performance risk adjustment is based on its CDS rate. At December 31, 2025 and 2024, the Company had no derivative contracts that contained credit-risk-related contingent features.
Cash Flow Hedges
The Company, at times, uses certain commodity derivative contracts to protect against commodity price changes related to forecasted raw material and component purchases. The Company had no material commodity derivative contracts at December 31, 2025 and 2024.
The Company manages its interest rate risk by balancing its exposure to fixed and variable rates while attempting to optimize its interest costs. The Company, at times, selectively uses interest rate swaps and options to reduce market value risk associated with changes in interest rates. At December 31, 2025 and 2024, the Company had no outstanding interest rate swaps or options.
The Company uses foreign currency forward and option contracts to protect against exchange rate movements for forecasted cash flows, including capital expenditures, purchases, operating expenses or sales transactions designated in currencies other than the functional currency of the operating unit. Foreign currency derivative contracts require the Company, at a future date, to either buy or sell foreign currency in exchange for the operating units’ local currency.
Effectiveness for cash flow hedges is assessed at the inception of the hedging relationship and quarterly, thereafter. Gains and losses arising from these contracts that are included in the assessment of effectiveness are deferred into accumulated other comprehensive income (loss) (“AOCI”) and reclassified into income as the underlying operating transactions are recognized. These realized gains or losses offset the hedged transaction and are recorded on the same line in the statement of operations. The initial value of any component excluded from the assessment of effectiveness is recognized in income using a systematic and rational method over the life of the hedging instrument. Any difference between the change in fair value of the excluded component and amounts recognized in income under that systematic and rational method is recognized in AOCI.
At December 31, 2025, the following notional amounts related to foreign currency derivative contracts were outstanding, which mature through the December, 2027:
| (in millions) | Notional Amount1 | |
|---|---|---|
| Traded currency | Notional in Traded Currency | Notional in Approximate U.S. Dollar |
| Euro | 103 | $122 |
| U.S. Dollar | 690 | $690 |
| Mexican Peso | 3,226 | $179 |
| Polish Zloty | 632 | $176 |
| Hungarian Forint | 14,863 | $45 |
| British Pound | 30 | $41 |
| Swiss Franc | 28 | $36 |
1 Table above excludes non-significant traded currency pairings with total notional amounts less than $10 million U.S. Dollar equivalent as of December 31, 2025.
Net Investment Hedges
In addition, the Company is also exposed to the risk that adverse changes in foreign currency exchange rates could impact its net investment in non-U.S. subsidiaries.
The Company selectively uses cross-currency swaps to hedge that foreign currency exposure. At December 31, 2025 and 2024, the following cross-currency swap contracts were outstanding and mature through August, 2030:
| Cross-currency swaps | ||
|---|---|---|
| (in millions) | December 31, 2025 | December 31, 2024 |
| U.S. Dollar to Euro: | ||
| Fixed receiving notional | $400 | $1,100 |
| Fixed paying notional | €355 | €976 |
| U.S. Dollar to Euro: | ||
| Fixed receiving notional | $500 | $500 |
| Fixed paying notional | €470 | €470 |
| U.S. Dollar to Euro: | ||
| Fixed receiving notional | $500 | $— |
| Fixed paying notional | €450 | €— |
| U.S. Dollar to Euro: | ||
| Fixed receiving notional | $200 | $— |
| Fixed paying notional | €179 | €— |
| U.S. Dollar to Japanese Yen: | ||
| Fixed receiving notional | $100 | $100 |
| Fixed paying notional | ¥12,724 | ¥12,724 |
During the year ended December 31, 2025, the Company unwound $700 million of cross-currency swap contracts originally maturing in July 2027, resulting in a cash outflow of approximately $4 million. The corresponding loss is expected to remain in AOCI until the net investment is sold, completely liquidated or substantially liquidated. Concurrently, the Company executedtwo U.S. Dollar to Euro cross-currency swap contracts of $500 million maturing in July 2028 and $200 million maturing in August 2030.
In April 2024, the Company terminated its $500 million cross-currency swap contract originally maturing in March 2025, resulting in cash proceeds of $23 million, the corresponding gain is expected to remain in accumulated other comprehensive loss until the net investment is sold, completely liquidated or substantially liquidated. Concurrently, the Company executed a $500 million cross-currency swap contract maturing in March 2029.
In addition, the Company has designated the €1,000 million 1.000% Senior Notes due May 19, 2031, as a net investment hedge of the foreign currency exposure of its investments in certain Euro-denominated subsidiaries. Refer to Note 14, “Debt,” to the Consolidated Financial Statements for more information.
The Company assesses the effectiveness for net investment hedges at the inception of the hedging relationship and quarterly, thereafter. Gains and losses arising from these contracts that are included in the assessment of effectiveness are deferred into foreign currency translation adjustments and only released when the subsidiary being hedged is sold or substantially liquidated. The initial value of any component excluded from the assessment of effectiveness is recognized in income using a systematic and rational method over the life of the hedging instrument. Any difference between the change in fair value of the excluded component and amounts recognized in income under that systematic and rational method is recognized in AOCI.
Fair Value of Derivative Instruments in the Balance Sheet
At December 31, 2025 and 2024, the following amounts were recorded in the Consolidated Balance Sheets as being payable to or receivable from counterparties for derivative instruments under ASC Topic 815, “Derivatives and Hedging”:
| (in millions) | Assets | Liabilities | ||||
|---|---|---|---|---|---|---|
| Derivatives designated as hedging instruments Under 815: | Location | December 31, 2025 | December 31, 2024 | Location | December 31, 2025 | December 31, 2024 |
| Foreign currency | Prepayments and other current assets | $18 | $18 | Other current liabilities | $16 | $23 |
| Foreign currency | Other non-current assets | $4 | $5 | Other non-current liabilities | $3 | $5 |
| Net investment hedges | Other non-current assets | $23 | $84 | Other non-current liabilities | $94 | $— |
| Derivatives not designated as hedging instruments: | ||||||
| Foreign currency | Prepayments and other current assets | $— | $1 | Other current liabilities | $— | $4 |
Effect of Derivatives on the Statements of Operations and Statements of Comprehensive Income (Loss)
The table below shows deferred gains (losses) reported in AOCI as well as the amount expected to be reclassified to income in one year or less for designated hedges. The amount expected to be reclassified to income in one year or less assumes no change in the current relationship of the hedged item at December 31, 2025 market rates.
| (in millions) · Deferred gain (loss) in AOCI at · Gain (loss) expected to be reclassified to income in one year or less | |||
|---|---|---|---|
| Contract type · December 31, 2025 · December 31, 2024 | |||
| Cash flow hedges: | |||
| Foreign currency | $7 | $(7) | $(1) |
| Net investment hedges: | |||
| Cross-currency swaps | $(71) | $84 | $— |
| Foreign currency-denominated debt | 29 | 168 | — |
| Total | $(35) | $245 | $(1) |
Derivative instruments designated as hedging instruments as defined by ASC Topic 815 held during the period resulted in the gains and losses recorded in income shown in the table below.
| (in millions) | Net sales | Cost of sales | Selling, general and administrative expenses | Other comprehensive income (loss) |
|---|---|---|---|---|
| Total amounts of earnings and other comprehensive income (loss) line items in which the effects of cash flow hedges are recorded | $14,316 | $11,642 | $1,304 | $221 |
| Gain (loss) on cash flow hedging relationships: | ||||
| Foreign currency: | ||||
| Gain (loss) recognized in other comprehensive income | $9 | |||
| Gain (loss) reclassified from AOCI to income | $— | $(5) | $(2) | $— |
| (in millions) | Net sales | Cost of sales | Selling, general and administrative expenses | Other comprehensive income (loss) |
|---|---|---|---|---|
| Total amounts of earnings and other comprehensive income (loss) line items in which the effects of cash flow hedges are recorded | $14,086 | $11,438 | $1,350 | $(192) |
| Gain (loss) on cash flow hedging relationships: | ||||
| Foreign currency: | ||||
| Gain (loss) recognized in other comprehensive income | $(2) | |||
| Gain (loss) reclassified from AOCI to income | $3 | $33 | $(1) | $— |
| (in millions) | Net sales | Cost of sales | Selling, general and administrative expenses | Other comprehensive income (loss) |
|---|---|---|---|---|
| Total amounts of earnings and other comprehensive income (loss) line items in which the effects of cash flow hedges are recorded | $14,198 | $11,630 | $1,316 | $48 |
| Gain (loss) on cash flow hedging relationships: | ||||
| Foreign currency: | ||||
| Gain (loss) recognized in other comprehensive income | $59 | |||
| Gain (loss) reclassified from AOCI to income | $— | $— | $34 | $— |
There were no gains or losses recorded in income related to components excluded from the assessment of effectiveness for derivative instruments designated as cash flow hedges for the periods presented.
Gains and losses on derivative instruments designated as net investment hedges were recognized in other comprehensive income (loss) during the periods presented below.
| (in millions) | Year Ended December 31, | ||
|---|---|---|---|
| Net investment hedges | 2025 | 2024 | 2023 |
| Cross-currency swaps | $(155) | $72 | $(55) |
| Foreign currency-denominated debt | $(138) | $68 | $(33) |
Derivatives designated as net investment hedge instruments, as defined by ASC Topic 815 held during the period resulted in the following gains recorded in Interest expense on components excluded from the assessment of effectiveness:
| (in millions) | Year Ended December 31, | ||
|---|---|---|---|
| Net investment hedges | 2025 | 2024 | 2023 |
| Cross-currency swaps | $24 | $23 | $25 |
There were no gains or losses recorded in income related to components excluded from the assessment of effectiveness for foreign currency-denominated debt designated as net investment hedges. There were no gains and losses reclassified from AOCI for net investment hedges during the periods presented.
Derivatives Not Designated as Hedges
Derivatives not designated as hedging instruments are used to hedge remeasurement exposures of monetary assets and liabilities denominated in currencies other than the operating units' functional currency. These derivatives resulted in gains (losses) recorded in income as shown in the table below.
| (in millions) | Year Ended December 31, | |||
|---|---|---|---|---|
| Contract type | Location | 2025 | 2024 | 2023 |
| Foreign currency | Selling, general and administrative expenses | $— | $2 | $(15) |
NOTE 18 RETIREMENT BENEFIT PLANS
The Company sponsors various defined contribution savings plans, primarily in the U.S., that allow employees to contribute a portion of their pre-tax and/or after-tax income in accordance with plan specified guidelines. Under specified conditions, the Company will make contributions to the plans and/or match a percentage of the employee contributions up to certain limits. Total expense related to the defined contribution plans was $44 million, $46 million and $45 million in the years ended December 31, 2025, 2024 and 2023, respectively.
The Company has a number of defined benefit pension plans and other postemployment benefit plans covering eligible salaried and hourly employees and their dependents. The defined pension benefits provided are primarily based on (i) years of service and (ii) average compensation or a monthly retirement benefit amount. The Company provides defined benefit pension plans in Germany, India, Italy, Japan, Mexico, Poland, South Korea, Sweden, Switzerland, Thailand, Turkey, U.K. and the U.S. The other postemployment benefit plans, which provide medical benefits, are unfunded plans. The Company’s U.S. and U.K. defined benefit plans are frozen, and no additional service cost is being accrued. All pension and other postemployment benefit plans in the U.S. have been closed to new employees. The measurement date for all plans is December 31.
In August 2025, the Company executed an amendment to the plan document of one of the Company’s U.S. defined benefit pension plans (“U.S. Pension Plan”) to terminate the plan effective October 31, 2025. The termination of the U.S. Pension Plan is expected to take up to eighteen months to complete. As part of the termination process, the Company expects to settle benefit obligations under the U.S. Pension Plan through a combination of lump sum payments to eligible plan participants and the purchase of a group annuity contract, under which future benefit obligations and administration will be transferred to a third-party insurance company. Such settlements will be funded primarily from plan assets. At December 31, 2025, the projected benefit obligation of the U.S. Pension Plan’s exceeded fair value of plan assets by $4 million under U.S. GAAP.
In December 2024, the Company entered into a second buy-in contract (the first buy-in contract was entered into in 2019) with an insurance company related to its U.K. pension plan. Pursuant to this agreement, the Company liquidated approximately $50 million of pension plan assets to invest in an insurance annuity. At December 31, 2025, the U.K. pension plan had plan assets of $131 million, all held by the insurance company. The projected benefit obligation of the U.K. pension plan at December 31, 2025 was $104 million under U.S. GAAP. The U.K. pension plan was overfunded by $27 million as of December 31, 2025, under U.S. GAAP.
The PHINIA-related benefits (costs) are included in the table below for periods prior to the Spin-Off, as they are not reported as discontinued operations in accordance with ASC Topic 205-20, “Discontinued Operations”.
The following table summarizes the expenses for the Company’s defined contribution and defined benefit pension plans and the other postemployment benefit plans:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| Defined contribution expense | $44 | $46 | $45 |
| Defined benefit pension expense | 26 | 26 | 26 |
| Total | $70 | $72 | $71 |
The following provides a roll forward of the plans’ benefit obligations, plan assets, funded status and recognition in the Consolidated Balance Sheets:
| Pension benefits · Other postemployment benefits | ||||||
|---|---|---|---|---|---|---|
| Year Ended December 31, | ||||||
| 2025 · 2024 · Year Ended December 31, | ||||||
| (in millions) | U.S. | Non-U.S. | U.S. | Non-U.S. | 2025 | 2024 |
| Change in projected benefit obligation: | ||||||
| Projected benefit obligation, January 1 | $121 | $451 | $131 | $478 | $29 | $33 |
| Service cost | — | 15 | — | 13 | — | — |
| Interest cost | 6 | 19 | 6 | 19 | 1 | 1 |
| Plan amendments | — | — | — | (1) | — | — |
| Settlement and curtailment | — | (11) | — | (6) | (1) | — |
| Actuarial loss (gain) | 14 | (38) | (3) | — | 2 | (1) |
| Currency translation | — | 52 | — | (32) | — | — |
| Benefits paid | (12) | (21) | (13) | (20) | (4) | (4) |
| Projected benefit obligation, December 311 | $129 | $467 | $121 | $451 | $27 | $29 |
| Change in plan assets: | ||||||
| Fair value of plan assets, January 1 | $126 | $380 | $123 | $392 | ||
| Actual return on plan assets | 10 | 13 | — | 14 | ||
| Employer contribution | 1 | 22 | 16 | 23 | ||
| Plan participants’ contribution | — | — | — | 1 | ||
| Settlements | — | (4) | — | (9) | ||
| Currency translation | — | 43 | — | (21) | ||
| Other | — | (1) | — | — | ||
| Benefits paid | (12) | (21) | (13) | (20) | ||
| Fair value of plan assets, December 31 | $125 | $432 | $126 | $380 | ||
| Funded status | $(4) | $(35) | $5 | $(71) | $(27) | $(29) |
| Amounts in the Consolidated Balance Sheets consist of: | ||||||
| Non-current assets | $— | $76 | $8 | $44 | $— | $— |
| Current liabilities | (3) | (7) | (1) | (5) | (4) | (4) |
| Non-current liabilities | (1) | (104) | (2) | (110) | (23) | (25) |
| Net amount | $(4) | $(35) | $5 | $(71) | $(27) | $(29) |
| Amounts in accumulated other comprehensive loss consist of: | ||||||
| Net actuarial loss | $86 | $72 | $78 | $103 | $(2) | $(4) |
| Net prior service cost (credit) | — | 1 | (1) | 1 | (6) | (7) |
| Net amount | $86 | $73 | $77 | $104 | $(8) | $(11) |
| Total accumulated benefit obligation for all plans | $129 | $432 | $121 | $423 | ||
1 The increase in the projected benefit obligation was primarily due to the impact of foreign currency exchange and net periodic pension cost, offset by actuarial gains and benefits paid during the period. The main driver of the actuarial gains was an increase in the weighted average discount rate for the Non-U.S. plans.
The funded status of pension plans with accumulated benefit obligations in excess of plan assets is as follows:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Accumulated benefit obligation | $(284) | $(180) |
| Plan assets | 196 | 85 |
| Deficiency | $(88) | $(95) |
| Pension deficiency by country: | ||
| United States | $(4) | $(2) |
| Germany | (17) | (32) |
| Other | (67) | (61) |
| Total pension deficiency | $(88) | $(95) |
The funded status of pension plans with projected benefit obligations in excess of plan assets is as follows:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Projected benefit obligation | $(322) | $(214) |
| Plan assets | 210 | 97 |
| Deficiency | $(112) | $(117) |
| Pension deficiency by country: | ||
| United States | $(4) | $(2) |
| United Kingdom | — | — |
| Germany | (17) | (32) |
| Other | (91) | (83) |
| Total pension deficiency | $(112) | $(117) |
The weighted average asset allocations of the Company’s funded pension plans and target allocations by asset category are as follows:
| December 31, · Target Allocation | |||
|---|---|---|---|
| 2025 · 2024 | |||
| U.S. Plans: | |||
| Alternative credit, real estate, cash and other | 35% | 26% | 30% - 40% |
| Fixed income securities | 61% | 61% | 57% - 67% |
| Equity securities | 4% | 13% | —% - 9% |
| 100% | 100% | ||
| Non-U.S. Plans: | |||
| Insurance contract, real estate, cash and other | 46% | 44% | 41% - 51% |
| Fixed income securities | 33% | 37% | 29% - 39% |
| Equity securities | 21% | 19% | 16% - 26% |
| 100% | 100% | ||
The Company’s investment strategy is to maintain actual asset weightings within a preset range of target allocations. The Company believes these ranges represent an appropriate risk profile for the planned benefit payments of the plans based on the timing of the estimated benefit payments. In each asset category, separate portfolios are maintained for additional diversification. Investment managers are retained in each asset category to manage each portfolio against its benchmark. Each investment manager has appropriate investment guidelines. In addition, the entire portfolio is evaluated against a relevant peer group. The defined benefit pension plans did not hold any Company securities as investments as of December 31, 2025 and 2024. A portion of pension assets is invested in common and commingled trusts.
The Company expects to contribute approximately $25 million into its defined benefit pension plans during 2026. Of the $25 million in projected 2026 contributions, $8 million are contractually obligated, while any remaining payments would be discretionary.
Refer to Note 16, “Fair Value Measurements,” to the Consolidated Financial Statements for more detail surrounding the fair value of each major category of plan assets, as well as the inputs and valuation techniques used to develop the fair value measurements of the plans’ assets at December 31, 2025 and 2024.
The PHINIA-related net periodic costs (income) are included in the table below for period prior to the Spin-Off, as they are not reported as discontinued operations in accordance with ASC Topic 205-20, “Discontinued Operations”.
See the table below for a breakout of net periodic benefit cost between U.S. and non-U.S. pension plans:
| Pension benefits · Other postemployment benefits | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Year Ended December 31, | |||||||||
| 2025 · 2024 · 2023 · Year Ended December 31, | |||||||||
| (in millions) | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | 2025 | 2024 | 2023 |
| Service cost | $— | $15 | $— | $13 | $— | $11 | $— | $— | $— |
| Interest cost | 6 | 19 | 6 | 19 | 7 | 42 | 1 | 1 | 2 |
| Expected return on plan assets | (6) | (16) | (6) | (15) | (6) | (37) | — | — | — |
| Settlements, curtailments and other | — | — | — | 1 | — | 4 | — | — | — |
| Amortization of unrecognized prior service credit | (1) | — | (1) | — | (1) | — | (1) | (1) | (2) |
| Amortization of unrecognized loss | 4 | 5 | 4 | 5 | 3 | 3 | — | — | — |
| Net periodic cost | $3 | $23 | $3 | $23 | $3 | $23 | $— | $— | $— |
The components of net periodic benefit cost other than the service cost component are included in Other postretirement expense in the Consolidated Statements of Operations.
The Company’s weighted average assumptions used to determine the benefit obligations for its defined benefit pension and other postemployment benefit plans were as follows:
| December 31, | ||
|---|---|---|
| (percent) | 2025 | 2024 |
| U.S. pension plans: | ||
| Discount rate | 4.14 | 5.54 |
| Rate of compensation increase | N/A | N/A |
| U.S. other postemployment benefit plans: | ||
| Discount rate | 4.87 | 5.39 |
| Rate of compensation increase | N/A | N/A |
| Non-U.S. pension plans: | ||
| Discount rate1 | 4.64 | 4.26 |
| Rate of compensation increase | 3.26 | 3.43 |
1 Includes 5.46% and 5.57% for the U.K. pension plans for December 31, 2025 and 2024, respectively.
The Company’s weighted average assumptions used to determine the net periodic benefit cost/(income) for its defined benefit pension and other postemployment benefit plans were as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (percent) | 2025 | 2024 | 2023 |
| U.S. pension plans: | |||
| Discount rate | 5.54 | 5.14 | 5.47 |
| Effective interest rate on benefit obligation | 5.24 | 5.08 | 5.34 |
| Expected long-term rate of return on assets | 4.75 | 5.00 | 5.00 |
| Average rate of increase in compensation | N/A | N/A | N/A |
| U.S. other postemployment plans: | |||
| Discount rate | 5.39 | 5.10 | 5.41 |
| Effective interest rate on benefit obligation | 5.11 | 5.06 | 5.29 |
| Expected long-term rate of return on assets | N/A | N/A | N/A |
| Average rate of increase in compensation | N/A | N/A | N/A |
| Non-U.S. pension plans: | |||
| Discount rate1 | 4.26 | 4.23 | 4.85 |
| Effective interest rate on benefit obligation | 4.13 | 4.24 | 4.88 |
| Expected long-term rate of return on assets2 | 4.33 | 4.10 | 4.90 |
| Average rate of increase in compensation | 3.43 | 3.32 | 3.58 |
1 Includes 5.57%,4.61% and 4.94% for the U.K. pension plans for December 31, 2025, 2024 and 2023, respectively.
2 Includes 4.75%,4.00% and 5.30% for the U.K. pension plans for December 31, 2025, 2024 and 2023, respectively.
The Company's approach to establishing the discount rate is based upon the market yields of high-quality corporate bonds, with appropriate consideration of each plan's defined benefit payment terms and duration of the liabilities. In determining the discount rate, the Company utilizes a full-yield approach in the estimation of service and interest components by applying the specific spot rates along the yield curve used in the determination of the benefit obligation to the relevant projected cash flows.
The Company determines its expected return on plan assets assumptions by evaluating estimates of future market returns and each plans’ asset allocation. The Company also considers the impact of active management of the plans’ invested assets.
The estimated future benefit payments for the pension and other postemployment benefits are as follows:
| Pension benefits · Other postemployment benefits | |||
|---|---|---|---|
| (in millions) | |||
| Year · U.S. · Non-U.S. | |||
| 2026 | $127 | $29 | $4 |
| 2027 | 1 | 29 | 4 |
| 2028 | — | 29 | 3 |
| 2029 | — | 30 | 3 |
| 2030 | — | 31 | 3 |
| 2031-2035 | — | 167 | 9 |
The weighted average rate of increase in the per capita cost of covered health care benefits is projected to range from 6.75% in 2026 down to an ultimate trend rate of 4.75%.
NOTE 19 STOCK-BASED COMPENSATION
The Company has granted restricted common stock and restricted stock units (collectively, “restricted stock”) and performance stock units as long-term incentive awards to employees and non-employee directors under the BorgWarner Inc. 2018 Stock Incentive Plan, as amended (“2018 Plan”) and the BorgWarner Inc. 2023 Stock Incentive Plan (“2023 Plan”). The Company’s Board of Directors adopted the 2023 Plan as a replacement to the 2018 Plan in February 2023, and the Company’s stockholders approved the 2023 Plan at the annual meeting of stockholders on April 26, 2023. The 2023 Plan authorizes the issuance of a total of 11.3 million shares and approximately 3.9 million shares were available for future issuance as of December 31, 2025.
Restricted Stock: The value of restricted stock is determined by the market value of the Company’s common stock at the date of grant. In 2025, restricted stock in the amount of 1.0 million shares were granted to employees and less than 0.1 million shares were granted to non-employee directors. The value of the awards is recognized as compensation expense ratably over the restriction periods, generallytwo orthree years. As of December 31, 2025, there was $30 million of unrecognized compensation expense related to restricted stock that will be recognized over a weighted average period of approximately 1.6 years.
Restricted stock compensation expense from continuing operations recorded in the Consolidated Statements of Operations is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions, except per share data) | 2025 | 2024 | 2023 |
| Restricted stock compensation expense | $37 | $36 | $37 |
| Restricted stock compensation expense, net of tax | $28 | $27 | $28 |
A summary of the status of the Company’s nonvested restricted stock for employees and non-employee directors is as follows:
| Shares subject to restriction (thousands) | Weighted average grant date fair value | |
|---|---|---|
| Nonvested at January 1, 2023 | 2,373 | $42.47 |
| Granted | 1,099 | $48.19 |
| Vested | (917) | $39.80 |
| Forfeited | (111) | $44.63 |
| PHINIA Spin-Off awards transferred1 | (389) | $45.80 |
| PHINIA Spin-Off adjustment2 | 274 | $— |
| Nonvested at December 31, 2023 | 2,329 | $40.57 |
| Granted | 1,317 | $33.75 |
| Vested | (923) | $44.21 |
| Forfeited | (198) | $43.04 |
| Nonvested at December 31, 2024 | 2,525 | $35.49 |
| Granted | 1,039 | $31.21 |
| Vested | (1,068) | $44.11 |
| Forfeited | (222) | $35.89 |
| Nonvested at December 31, 2025 | 2,274 | $29.45 |
1 Represents the cancellation of awards outstanding as of Distribution Date held by PHINIA employees. PHINIA employees were granted PHINIA restricted stock after the Spin-Off replacing the cancelled awards.
2 Represents the adjustment of unvested awards using a conversion ratio of 1.13 to 1 to preserve the intrinsic value of the awards prior to Spin-Off as authorized by the 2023 Plan and 2018 Plan.
Performance stock units: The Company grants performance stock units to members of senior management that vest at the end ofthree-year periods based the following metrics:
Total Stockholder Return Units: This performance metric is based on the Company’s market performance in terms of total shareholder return relative to a peer group of automotive companies. Based on the Company’s relative ranking within the performance peer group, it is possible for awards to vest in a range of 0% up to 200% of target shares.
The Company recognizes compensation expense relating to this performance stock unit award ratably over the performance period regardless of whether the market conditions are expected to be achieved. Compensation expense associated with the performance stock unit award is calculated using a lattice model (Monte Carlo simulation).
As of December 31, 2025, there was $15 million of unrecognized compensation expense related to total stockholder return units that will be recognized over a weighted average period of approximately 1.8 years.
eProduct Revenue Mix: Introduced in the first quarter of 2021, this performance metric is based on the Company’s total revenue derived from eProducts in relation to its total proforma revenue in the third year of the performance period. Based on the Company’s eProduct revenue mix, it is possible for awards to vest in a range of 0% up to 200% of target shares.
The value of this performance stock unit award is determined by the market value of the Company’s common stock at the date of grant. The Company recognizes compensation expense relating to this performance stock unit award over the performance period based on the number of shares expected to vest at the end of each reporting period. The actual performance of the Company is evaluated quarterly and the expense is adjusted according to projections at that time.
As of December 31, 2025, these awards were fully expensed.
Cumulative Free Cash Flow: Introduced in the first quarter of 2021, this performance metric is based on the Company’s performance in terms of its operating cash flow less capital expenditures over thethree-year performance periods. Based on the Company’s cumulative free cash flow, it is possible for awards to vest in a range of 0% up to 200% of target shares.
The value of this performance stock unit award is determined by the market value of the Company’s common stock at the date of grant. The Company recognizes compensation expense relating to this performance stock unit award over the performance period based on the number of shares expected to vest at the end of each reporting period. The actual performance of the Company is evaluated quarterly and the expense is adjusted according to projections at that time.
As of December 31, 2025, these awards were fully expensed.
eProduct Revenue: Introduced in the first quarter of 2022, this performance metric is based on the amount of the Company’s total revenue derived from eProducts in the third year of the performance period. Based on the Company’s eProduct revenue, it is possible for awards to vest in a range of 0% up to 200% of target shares.
The value of this performance stock unit award is determined by the market value of the Company’s common stock at the date of grant. The Company recognizes compensation expense relating to this performance stock unit award over the performance period based on the number of shares expected to vest at the end of each reporting period. The actual performance of the Company is evaluated quarterly and the expense is adjusted according to projections at that time.
As of December 31, 2025, there was $2 million of unrecognized compensation expense related to the eProduct revenue units that will be recognized over a weighted average period of approximately 1.0 year. The unrecognized amount of compensation expense is based on projected performance as of December 31, 2025.
eProduct Adjusted Operating Margin: Introduced in the first quarter of 2024, this performance metric is based on the amount of the Company’s operating income derived from eProducts adjusted to eliminate the impact of expenses not reflective of the Company’s ongoing operations attributable to eProducts, divided by externally reported sales derived from eProducts, both measured in the third year of the performance period. Based on the Company’s eProduct Adjusted Operating Margin, it is possible for awards to vest in a range of 0% up to 200% of target shares.
The value of this performance stock unit award is determined by the market value of the Company’s common stock at the date of grant. The Company recognizes compensation expense relating to this performance stock unit award over the performance period based on the number of shares expected to vest at the end of each reporting period. The actual performance of the Company is evaluated quarterly and the expense is adjusted according to projections at that time.
As of December 31, 2025, there was $2 million of unrecognized compensation expense related to the eProduct Adjusted Operating Margin units that will be recognized over a weighted average period of approximately 1.0 year. The unrecognized amount of compensation expense is based on projected performance as of December 31, 2025.
Foundational Adjusted Operating Margin: Introduced in the first quarter of 2024, this performance metric is based on the amount of the Company’s operating income derived from Foundational products adjusted to eliminate the impact of expenses not reflective of the Company’s ongoing operations attributable to Foundational products, divided by externally reported sales on Foundational products, both measured in the third year of the performance period. Based on the Company’s Foundational Adjusted Operating Margin, it is possible for awards to vest in a range of 0% up to 200% of target shares.
The value of this performance stock unit award is determined by the market value of the Company’s common stock at the date of grant. The Company recognizes compensation expense relating to this performance stock unit award over the performance period based on the number of shares expected to vest at the end of each reporting period. The actual performance of the Company is evaluated quarterly and the expense is adjusted according to projections at that time.
As of December 31, 2025, there was $2 million of unrecognized compensation expense related to the Foundational Adjusted Operating Margin units that will be recognized over a weighted average period of approximately 1.0 year. The unrecognized amount of compensation expense is based on projected performance as of December 31, 2025.
Relative Revenue Growth: Introduced in the first quarter of 2025, this performance metric is defined as the percentage by which the Company’s annual percentage change in revenue, excluding the impact of changes in foreign currency exchange rates and merger, acquisition and divestiture activity, for the performance period exceeds the annual percentage change in the market for the performance period. Based on the Company’s Relative Revenue Growth, it is possible for awards to vest in a range of 0% up to 200% of target shares.
The value of this performance stock unit award is determined by the market value of the Company’s common stock at the date of grant. The performance against this metric is determined by change in vehicle production over the performance period among the passenger car and on-highway commercial vehicle markets across the geographic markets of North America, Europe, China and Rest of World in proportion to the Company’s revenue distribution at the end of the performance period across those same geographic market segments.
As of December 31, 2025, there was $5 million of unrecognized compensation expense related to the Relative Revenue Growth units that will be recognized over a weighted average period of approximately 2.0 years. The unrecognized amount of compensation expense is based on projected performance as of December 31, 2025.
Cumulative Adjusted Earnings Per Share: Introduced in the first quarter of 2025, this performance metric is based upon the Company’s Cumulative Adjusted Earnings per Share calculated by adding the Adjusted Earnings per Share for fiscal years 2025, 2026 and 2027 together. Based on the Company’s Cumulative Adjusted Earnings per Share, it is possible for awards to vest in a range of 0% up to 200% of target shares.
The value of this performance stock unit award is determined by the market value of the Company’s common stock at the date of grant. The performance against this metric is determined as net earnings attributable to BorgWarner Inc. adjusted to eliminate the impact of restructuring expense, merger, acquisition and divestiture expense, other net expenses, discontinued operations; other gains and losses not reflective of the Company’s ongoing operations, and related tax effects, divided by the weighted average shares of common stock outstanding, including dilutive shares.
As of December 31, 2025, there was $5 million of unrecognized compensation expense related to the Cumulative Adjusted Earnings per Share units that will be recognized over a weighted average period of approximately 2.0 years. The unrecognized amount of compensation expense is based on projected performance as of December 31, 2025.
The amounts expensed and common stock issued from continuing operations for performance stock units for the years ended December 31, 2025, 2024 and 2023 were as follows:
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||
| Expense (in millions) | Number of shares issued (in thousands) | Expense (in millions) | Number of shares issued (in thousands) | Expense (in millions) | Number of shares issued (in thousands) | |
| Total Stockholder Return | $15 | 232 | $8 | 257 | $8 | 107 |
| Other Performance-Based | 14 | 400 | 18 | 558 | 13 | 313 |
| Total | $29 | 632 | $26 | 815 | $21 | 420 |
A summary of the status of the Company’s nonvested performance stock units for the years ended December 31, 2025, 2024 and 2023 was as follows:
| Total Stockholder Return | Other Performance-Based | |||
|---|---|---|---|---|
| Number of shares (in thousands) | Weighted average grant date fair value | Number of shares (in thousands) | Weighted average grant date fair value | |
| Nonvested at January 1, 2023 | 250 | $76.68 | 765 | $45.51 |
| Granted | 135 | $79.39 | 405 | $48.06 |
| Vested | (114) | $70.39 | (341) | $45.14 |
| Forfeited | (11) | $68.66 | (34) | $44.96 |
| PHINIA Spin-Off awards transferred1 | (22) | $72.33 | (67) | $46.03 |
| PHINIA Spin-Off adjustment2 | 35 | $— | 106 | $— |
| Nonvested at December 31, 2023 | 273 | $71.37 | 834 | $41.08 |
| Granted | 205 | $46.54 | 616 | $33.91 |
| Vested | (104) | $66.89 | (315) | $44.23 |
| Forfeited | (37) | $70.32 | (111) | $45.07 |
| Nonvested at December 31, 2024 | 337 | $57.72 | 1,024 | $35.36 |
| Granted | 553 | $40.92 | 583 | $31.23 |
| Vested | (144) | $62.25 | (431) | $37.04 |
| Forfeited | (25) | $44.70 | (40) | $32.42 |
| Nonvested at December 31, 2025 | 721 | $44.38 | 1,136 | $32.71 |
1 Represents the cancellation of awards outstanding as of Distribution Date held by PHINIA employees. PHINIA employees were granted PHINIA restricted stock after the Spin-Off replacing the cancelled awards.
2 Represents the adjustment of unvested awards using a conversion ratio of 1.13 to 1 to preserve the intrinsic value of the awards prior to Spin-Off as authorized by the 2023 Plan and 2018 Plan.
NOTE 20 ACCUMULATED OTHER COMPREHENSIVE LOSS
The following table summarizes the activity within accumulated other comprehensive loss:
| (in millions) | Foreign currency translation adjustments | Cash flow hedges | Defined benefit postretirement plans | Total |
|---|---|---|---|---|
| Beginning Balance, January 1, 2023 | $(750) | $4 | $(130) | $(876) |
| Comprehensive income (loss) before reclassifications | 27 | 59 | (9) | 77 |
| Income taxes associated with comprehensive income (loss) before reclassifications | 24 | — | (5) | 19 |
| Reclassification from accumulated other comprehensive income (loss) | — | (34) | 3 | (31) |
| Income taxes reclassified into net earnings | — | — | (1) | (1) |
| Spin-Off of PHINIA | (20) | (1) | 5 | (16) |
| Ending Balance December 31, 2023 | $(719) | $28 | $(137) | $(828) |
| Comprehensive income (loss) before reclassifications | (124) | (2) | 19 | (107) |
| Income taxes associated with comprehensive income (loss) before reclassifications | (39) | — | (2) | (41) |
| Reclassification from accumulated other comprehensive income (loss) | — | (35) | (7) | (42) |
| Income taxes reclassified into net earnings | — | — | (2) | (2) |
| Ending Balance December 31, 2024 | $(882) | $(9) | $(129) | $(1,020) |
| Comprehensive income (loss) before reclassifications | 124 | 9 | 30 | 163 |
| Income taxes associated with comprehensive income (loss) before reclassifications | 64 | — | (4) | 60 |
| Reclassification from accumulated other comprehensive income (loss) | — | 7 | (7) | — |
| Income taxes reclassified into net earnings | — | — | (2) | (2) |
| Ending Balance December 31, 2025 | $(694) | $7 | $(112) | $(799) |
The change in other comprehensive income for the Company’s noncontrolling interest entities is related to foreign currency translation.
NOTE 21 CONTINGENCIES
In the normal course of business, the Company is party to various commercial and legal claims, actions and complaints, including matters involving warranty claims, intellectual property claims, governmental investigations and related proceedings, general liability and other risks. It is not possible to predict with certainty whether the Company will ultimately be successful in any of these commercial and legal matters or what the impact might be. The Company does not believe that adverse outcomes in any of these commercial and legal claims, actions and complaints are reasonably likely to have a material adverse effect on the Company’s results of operations, financial position or cash flows. An adverse outcome could, nonetheless, be material to the results of operations or cash flows as the ultimate resolutions of these matters are inherently unpredictable.
On September 19, 2024, the Company commenced a lawsuit against PHINIA, seeking to recover from PHINIA approximately $120 million of value added tax (“VAT”) refunds that PHINIA received or expects to receive from governmental agencies as well as damages and interest. These refunds consisted of VAT paid by the Company in periods prior to or directly related to the Spin-Off that established PHINIA as an independent company. PHINIA responded to the lawsuit and also asserted counterclaims against the Company. On October 15, 2025, the Company entered into a settlement agreement (the “Settlement Agreement”) with PHINIA, pursuant to which PHINIA agreed to pay the Company $78 million, resolving the lawsuit and certain other matters relating to the Spin-Off. In connection with the Settlement Agreement, the Company and PHINIA also entered into an amended and restated tax matters agreement that, among other things, limits the Company’s responsibility to certain defined tax obligations. As a result, the Company recorded a net charge of $40 million during the year ended December 31, 2025, for the reduction of VAT-related receivables, the elimination of certain Company liabilities under the amended and restated tax matters agreement and related legal fees, which is included in Other operating expense, net in the Company’s Consolidated Statements of Operations. As of December 31, 2025, after giving effect to the Settlement Agreement and the $31 million payment received during the fourth quarter of 2025, the Company had assets related to these VAT refunds of approximately $47 million in Receivables, net in the Company’s Consolidated Balance Sheet.
Environmental
The Company and certain of its current and former direct and indirect corporate predecessors, subsidiaries and divisions have been identified by the United States Environmental Protection Agency and certain local environmental agencies and private parties as potentially responsible parties (“PRPs”) at various hazardous waste disposal sites under the Comprehensive Environmental Response, Compensation and Liability Act (“Superfund”) and equivalent state or local laws and, as such, may have been liable for the cost of clean-up and other remedial activities at 16 and 17 such sites as of December 31, 2025 and 2024, respectively. Responsibility for clean-up and other remedial activities at a Superfund site is typically shared among PRPs based on an allocation formula.
The Company believes that none of these matters, individually or in the aggregate, will have a material adverse effect on its results of operations, financial position or cash flows. Generally, this is because either the estimates of the maximum potential liability at a site are not material or the liability will be shared with other PRPs, although no assurance can be given with respect to the ultimate outcome of any such matter.
The Company had an accrual for environmental liabilities of $6 million and $5 million as of December 31, 2025 and 2024, respectively, included in Other current and Other non-current liabilities in the Consolidated Balance Sheets. As of December 31, 2025, this accrual, which relates tofour of the sites, is based on information available to the Company (which, in most cases, includes an estimate of allocation of liability among PRPs; the probability that other PRPs, many of which are large, solvent public companies, will fully pay the cost apportioned to them; currently available information from PRPs and/or federal or local environmental agencies concerning the scope of contamination and estimated remediation and consulting costs; and remediation alternatives). Clean-up and other remedial activities are complete or nearing completion at the other 12 sites, for which there was no accrual as of December 31, 2025.
NOTE 22 LEASES AND COMMITMENTS
The Company’s lease agreements primarily consist of real estate property, such as manufacturing facilities, warehouses and office buildings, in addition to personal property, such as vehicles, manufacturing and information technology equipment. The Company determines whether a contract is or contains a lease at contract inception. The majority of the Company’s lease arrangements are comprised of fixed payments, and a limited number of these arrangements include a variable payment component based on certain index fluctuations. As of December 31, 2025, a significant portion of the Company’s leases were classified as operating leases.
Generally, the Company’s operating leases have renewal options that extend the lease terms, and some include options to terminate the agreement or purchase the leased asset. The amortizable life of these assets is the lesser of its useful life or the lease term, including renewal periods reasonably assured of being exercised at lease inception.
All leases with an initial term of 12 months or less without an option to extend or purchase the underlying asset that the Company is reasonably certain to exercise (“short-term leases”) are not recorded on the Consolidated Balance Sheets, and lease expense is recognized on a straight-line basis over the lease term.
The following table presents the lease assets and lease liabilities as of December 31, 2025 and 2024:
| December 31, | |||
|---|---|---|---|
| (in millions) · 2025 · 2024 | |||
| Assets · Balance Sheet Location | |||
| Operating leases | Other non-current assets | $151 | $177 |
| Finance leases | Property, plant and equipment, net | 16 | 20 |
| Total lease assets | $167 | $197 | |
| Liabilities | |||
| Current | |||
| Operating leases | Other current liabilities | $36 | $38 |
| Finance leases | Notes payable and other short-term debt | 2 | 3 |
| Non-current | |||
| Operating leases | Other non-current liabilities | 122 | 144 |
| Finance leases | Long-term debt | 16 | 20 |
| Total lease liabilities | $176 | $205 | |
The following table presents lease obligations arising from obtaining leased assets for the years ended December 31, 2025 and 2024:
| December 31, | ||
|---|---|---|
| (in millions) | 2025 | 2024 |
| Operating leases | $7 | $66 |
| Finance leases | — | 2 |
| Total lease obligations | $7 | $68 |
The following table presents the maturity of lease liabilities as of December 31, 2025:
| (in millions) | Operating leases | Finance leases |
|---|---|---|
| 2026 | $39 | $4 |
| 2027 | 31 | 4 |
| 2028 | 25 | 4 |
| 2029 | 20 | 2 |
| 2030 | 15 | 2 |
| After 2030 | 74 | 7 |
| Total (undiscounted) lease payments | $204 | $23 |
| Less: Imputed interest | 46 | 5 |
| Present value of lease liabilities | $158 | $18 |
In the years ended December 31, 2025, 2024 and 2023, the Company recorded operating lease expense of $45 million, $41 million and $33 million, respectively.
In the years ended December 31, 2025, 2024 and 2023, the operating cash flows for operating leases were $44 million, $38 million and $33 million, respectively.
In the years ended December 31, 2025, 2024 and 2023, the Company recorded short-term lease costs of $26 million, $24 million and $29 million, respectively.
Finance lease costs and related cash flows were immaterial for the periods presented.
ASC Topic 842, “Leases”, requires that the rate implicit in the lease be used if readily determinable. Generally, implicit rates are not readily determinable in the Company’s agreements, so the incremental borrowing rate is used instead for such lease arrangements. The incremental borrowing rates are determined using rates specific to the term of the lease, economic environments where lease activity is concentrated, value of lease portfolio, and assuming full collateralization of the loans. The following table presents the terms and discount rates:
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Weighted average remaining lease term (years) | ||
| Operating leases | 8 | 8 |
| Finance leases | 7 | 7 |
| Weighted average discount rate | ||
| Operating leases | 5.8% | 5.7% |
| Finance leases | 6.5% | 6.3% |
NOTE 23 EARNINGS PER SHARE
The Company presents both basic and diluted earnings per share of common stock (“EPS”) amounts. Basic EPS is calculated by dividing net earnings attributable to BorgWarner Inc. by the weighted average shares of common stock outstanding during the reporting period. Diluted EPS is calculated by dividing net earnings attributable to BorgWarner Inc. by the weighted average shares of common stock and common stock equivalents outstanding during the reporting period.
The dilutive impact of stock-based compensation is calculated using the treasury stock method. The treasury stock method assumes that the Company uses the assumed proceeds from the exercise of awards to repurchase common stock at the average market price during the period. The assumed proceeds under the treasury stock method include the purchase price that the grantee will pay in the future and compensation cost for future service that the Company has not yet recognized. The dilutive effects of performance-based stock awards described in Note 19, “Stock-Based Compensation,” to the Consolidated Financial Statements are included in the computation of diluted earnings per share at the level the related performance criteria are met through the respective balance sheet date. There were 1.3 million,0.9 million and 0.7 million performance stock units excluded from the computation of the diluted earnings per share for the years ended December 31, 2025, 2024 and 2023, respectively. These units were excluded because the related performance criteria had not been met as of the balance sheet dates.
The following table reconciles the numerators and denominators used to calculate basic and diluted earnings per share of common stock:
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions except share and per share amounts) | 2025 | 2024 | 2023 |
| Basic earnings per share: | |||
| Net earnings from continuing operations | $277 | $367 | $632 |
| Weighted average shares of common stock outstanding | 214.2 | 223.5 | 232.8 |
| Basic earnings per share of common stock | $1.29 | $1.64 | $2.71 |
| Diluted earnings per share: | |||
| Net earnings from continuing operations | $277 | $367 | $632 |
| Weighted average shares of common stock outstanding | 214.2 | 223.5 | 232.8 |
| Effect of stock-based compensation | 2.2 | 1.3 | 1.6 |
| Weighted average shares of common stock outstanding, including dilutive shares | 216.4 | 224.8 | 234.4 |
| Diluted earnings per share of common stock | $1.28 | $1.63 | $2.70 |
NOTE 24 REPORTABLE SEGMENTS AND RELATED INFORMATION
The Company discloses segment information under four reportable segments, consistent with the operating segments that are evaluated by management, including the chief operating decision maker (“CODM”). The Company’s CODM is its Chief Executive Officer. The reportable segments are further described below. These segments are strategic business groups, which are managed separately as each represents a specific grouping of related automotive components and systems.
Turbos & Thermal Technologies. This segment’s products include turbochargers, eBoosters, eTurbos, emissions systems, thermal systems, gasoline ignition technology, smart remote actuators, powertrain sensors, cabin heaters, battery heaters and battery cooling systems.
Drivetrain & Morse Systems. This segment’s products include hydraulic controls, friction and mechanical clutch products for automatic transmissions and torque-management products, such as transfer cases for 4-wheel drive (“4WD”) and all-wheel drive (“AWD”) applications, electronic limited slip differentials (“eLSD”), and electric torque vectoring and axle disconnect systems. Additionally, the Drivetrain & Morse Systems products include chain systems and variable camshaft phasing products.
PowerDrive Systems. This segment’s products include power electronics such as inverters, onboard chargers, DC/DC converters and combination boxes, rotating electric machines, fully integrated drive modules (consisting of inverter, eMotor and gear reducer) and electronic controls.
Battery & Charging Systems. This segment’s products include high-performance lithium-ion battery systems for electrified bus-, truck- and off-highway applications.
In February 2025, the Company made the decision to exit its charging business within the Battery & Charging Systems reportable segment. This exit did not result in a change to the Company’s reportable segments. Refer to Note 2, “Acquisitions and Dispositions,” to the Consolidated Financial Statements for more information.
Segment Adjusted Operating Income (Loss) is the measure of segment income or loss used by the Company. Segment Adjusted Operating Income (Loss) is comprised of operating income for the Company’s reportable segments adjusted to exclude restructuring, merger, acquisition and divestiture expense, intangible asset amortization expense, impairment charges and other items not reflective of ongoing operating income or loss. The Company believes Segment Adjusted Operating Income (Loss) is most reflective of the operational profitability or loss of its reportable segments.
The Company’s CODM uses Segment Adjusted Operating Income (Loss) and the expenses disclosed below to assess the performance of its reportable segments. The CODM uses this information to assist with decisions about future growth, capital investments and cost reduction initiatives by reviewing trends in the business, monitoring variances to historical results and previously forecasted information and performing other analytical comparisons.
The following tables show net sales, segment expenses, Segment Adjusted Operating Income (Loss) and other segment information for the Company’s reportable segments. The segment expenses do not include non-comparable items that are excluded in the calculation of Segment Adjusted Operating Income (Loss):
Net Sales and Expenses by Reportable Segment
| Year ended December 31, 2025 | ||||||
|---|---|---|---|---|---|---|
| (in millions) | Turbos & Thermal Technologies | Drivetrain & Morse Systems | PowerDrive Systems | Battery & Charging Systems | Inter-segment eliminations | Total |
| Net sales - customers | $5,769 | $5,635 | $2,322 | $590 | $— | $14,316 |
| Net sales - inter-segment | 3 | 19 | 25 | — | (47) | — |
| Net sales | $5,772 | $5,654 | $2,347 | $590 | $(47) | $14,316 |
| Cost of sales | 4,602 | 4,430 | 1,995 | 555 | ||
| Selling, general and administrative expenses - R&D, net | 178 | 132 | 354 | 37 | ||
| Selling, general and administrative expenses - Other | 114 | 55 | 89 | 37 | ||
| Other segment items1 | (1) | (4) | (8) | — | ||
| Segment Adjusted Operating Income (Loss) | $879 | $1,041 | $(83) | $(39) | ||
| Year ended December 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| (in millions) | Turbos & Thermal Technologies | Drivetrain & Morse Systems | PowerDrive Systems | Battery & Charging Systems | Inter-segment eliminations | Total |
| Net sales - customers | $5,885 | $5,564 | $1,908 | $729 | $— | $14,086 |
| Net sales - inter-segment | 2 | 13 | 29 | — | (44) | — |
| Net sales | $5,887 | $5,577 | $1,937 | $729 | $(44) | $14,086 |
| Cost of sales | 4,724 | 4,413 | 1,648 | 681 | ||
| Selling, general and administrative expenses - R&D, net | 170 | 118 | 384 | 51 | ||
| Selling, general and administrative expenses - Other | 114 | 38 | 60 | 47 | ||
| Other segment items1 | 2 | (2) | (11) | (3) | ||
| Segment Adjusted Operating Income (Loss) | $877 | $1,010 | $(144) | $(47) | ||
| Year ended December 31, 2023 | ||||||
|---|---|---|---|---|---|---|
| (in millions) | Turbos & Thermal Technologies | Drivetrain & Morse Systems | PowerDrive Systems | Battery & Charging Systems | Inter-segment eliminations | Total |
| Net sales - customers | $6,007 | $5,543 | $2,102 | $546 | $— | $14,198 |
| Net sales - inter-segment | 5 | 6 | 64 | — | (75) | — |
| Net sales | $6,012 | $5,549 | $2,166 | $546 | $(75) | $14,198 |
| Cost of sales | 4,865 | 4,413 | 1,826 | 581 | ||
| Selling, general and administrative expenses - R&D, net | 175 | 122 | 362 | 44 | ||
| Selling, general and administrative expenses - Other | 100 | 49 | 73 | 40 | ||
| Other segment items1 | (2) | 7 | (5) | (3) | ||
| Segment Adjusted Operating Income (Loss) | $874 | $958 | $(90) | $(116) | ||
1 Other segment items include other income and expenses to derive Segment Adjusted Operating Income (Loss).
Segment Adjusted Operating Income (Loss)
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| Turbos & Thermal Technologies | $879 | $877 | $874 |
| Drivetrain & Morse Systems | 1,041 | 1,010 | 958 |
| PowerDrive Systems | (83) | (144) | (90) |
| Battery & Charging Systems | (39) | (47) | (116) |
| Segment Adjusted Operating Income | 1,798 | 1,696 | 1,626 |
| Corporate, including stock-based compensation | 261 | 279 | 278 |
| Impairment charges | 624 | 646 | 29 |
| Restructuring expense (Note 4) | 101 | 74 | 79 |
| Accelerated depreciation1 | 90 | 50 | 4 |
| Intangible asset amortization expense | 66 | 69 | 67 |
| Legal settlement (Note 21) | 40 | — | — |
| Costs to exit charging business (Note 2) | 32 | — | — |
| Impairment of investment | 16 | — | — |
| Chief Executive Officer ("CEO") transition compensation2 | 11 | — | — |
| Loss (gain) on sale of assets2 | 9 | 2 | (13) |
| Adjustments associated with Spin-Off related balances2 | 7 | 17 | — |
| Write-off customer incentive asset (Note 3) | 7 | — | — |
| Merger and acquisition expense, net2 | 5 | 2 | 23 |
| Loss (gain) on sale of businesses2 | 2 | 6 | (5) |
| Change in accounting method | — | (29) | — |
| Commercial contract settlement2 | — | 15 | — |
| Insurance recovery (Note 13) | (21) | — | — |
| Other non-comparable items | 12 | 19 | 4 |
| Equity in affiliates' earnings, net of tax | (35) | (27) | (30) |
| Unrealized and realized (gain) loss on equity and debt securities | (3) | 1 | 174 |
| Interest expense, net | 39 | 20 | 10 |
| Other postretirement expense | 11 | 13 | 15 |
| Earnings from continuing operations before income taxes and noncontrolling interest | $524 | $539 | $991 |
1 Accelerated depreciation represents charges related to property, plant and equipment that were decommissioned or are in the process of being decommissioned.
2 Refer to Note 6, “Other Operating Expense (Income), Net,” to the Consolidated Financial Statements for more information.
Segment Information
| Depreciation and amortization | Long-lived asset expenditures1 | |||||
|---|---|---|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 | 2025 | 2024 | 2023 |
| Turbos & Thermal Technologies | $171 | $177 | $170 | $188 | $170 | $184 |
| Drivetrain & Morse Systems | 214 | 246 | 215 | 101 | 115 | 134 |
| PowerDrive Systems | 184 | 164 | 127 | 149 | 291 | 384 |
| Battery & Charging Systems | 120 | 57 | 39 | 18 | 82 | 96 |
| Total | 689 | 644 | 551 | 456 | 658 | 798 |
| Corporate2 | 30 | 29 | 31 | 13 | 13 | 34 |
| Consolidated | $719 | $673 | $582 | $469 | $671 | $832 |
| Total assets | ||||||
| 2025 · 2024 · 2023 | ||||||
| Turbos & Thermal Technologies | $3,743 | $3,693 | $3,938 | |||
| Drivetrain & Morse Systems | 3,795 | 3,872 | 4,262 | |||
| PowerDrive Systems | 3,163 | 2,792 | 3,185 | |||
| Battery & Charging Systems | 460 | 1,082 | 1,335 | |||
| Total | 11,161 | 11,439 | 12,720 | |||
| Corporate2 | 2,608 | 2,554 | 1,733 | |||
| Consolidated | $13,769 | $13,993 | $14,453 | |||
1 Long-lived asset expenditures include capital expenditures and tooling outlays.
2 Corporate assets include cash and cash equivalents, investments and long-term receivables and deferred income taxes.
Geographic Information
During the year ended December 31, 2025, approximately 84% of the Company’s consolidated net sales were outside the U.S., attributing sales to the location of production rather than the location of the customer. Outside the U.S., China, Mexico, Germany, Poland, South Korea and Hungary exceeded 5% of consolidated net sales during the year ended December 31, 2025. The following table shows sales to customers and property, plant and equipment by country.
| Sales | Property, plant and equipment | |||||
|---|---|---|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 | 2025 | 2024 | 2023 |
| United States | $2,293 | $2,240 | $2,334 | $677 | $718 | $778 |
| Europe: | ||||||
| Germany | 1,624 | 1,680 | 1,669 | 220 | 352 | 393 |
| Poland | 1,245 | 1,160 | 1,121 | 393 | 356 | 342 |
| Hungary | 771 | 820 | 904 | 166 | 154 | 167 |
| Other Europe | 1,508 | 1,586 | 1,387 | 501 | 472 | 456 |
| Total Europe | 5,148 | 5,246 | 5,081 | 1,280 | 1,334 | 1,358 |
| China | 2,968 | 2,862 | 2,998 | 652 | 720 | 876 |
| Mexico | 1,741 | 1,644 | 1,759 | 325 | 412 | 374 |
| South Korea | 1,150 | 1,181 | 1,163 | 199 | 189 | 197 |
| Other foreign | 1,016 | 913 | 863 | 197 | 202 | 200 |
| Total | $14,316 | $14,086 | $14,198 | $3,330 | $3,575 | $3,783 |
Sales to Major Customers
Consolidated net sales to Volkswagen (including its subsidiaries) were approximately 13%,10% and 11% for the years ended December 31, 2025, 2024 and 2023. Consolidated net sales to Ford (including its subsidiaries) were approximately 12%,13% and 14% for the years ended December 31, 2025, 2024 and 2023, respectively. Such sales consisted of a variety of products to a variety of customer locations and regions. No other single customer accounted for more than 10% of consolidated net sales in any of the years presented.
Sales by Product Line
Sales of turbochargers for light vehicles represented approximately 21%,21% and 22% of consolidated net sales for the years ended December 31, 2025, 2024 and 2023, respectively. No other single product line accounted for more than 10% of consolidated net sales in any of the years presented.
NOTE 25 OPERATING CASH FLOWS AND OTHER SUPPLEMENTAL FINANCIAL INFORMATION
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| OPERATING ACTIVITIES OF CONTINUING OPERATIONS | |||
| Net earnings | $335 | $399 | $695 |
| Net loss from discontinued operations | — | (29) | (7) |
| Net earnings from continuing operations | 335 | 428 | 702 |
| Adjustments to reconcile net earnings from continuing operations to net cash provided by operating activities from continuing operations: | |||
| Depreciation and tooling amortization | 653 | 604 | 515 |
| Intangible asset amortization | 66 | 69 | 67 |
| Restructuring expense, net of cash paid | 36 | 6 | 66 |
| Stock-based compensation expense | 66 | 62 | 58 |
| Loss on sales of assets | 9 | — | — |
| Loss (gain) on sales of businesses | 2 | 6 | (5) |
| Gain on debt extinguishment | — | (10) | (28) |
| Asset impairments | 624 | 646 | 29 |
| Impairment of investment | 16 | — | — |
| Costs to exit charging business | 32 | — | — |
| Change in accounting method | — | (29) | — |
| Unrealized and realized (gain) loss on equity and debt securities | (3) | 1 | 174 |
| Deferred income tax benefit | (133) | (156) | (44) |
| Other non-cash adjustments | 3 | 8 | (25) |
| Adjustments to reconcile net earnings from continuing operations to net cash provided by operating activities from continuing operations | 1,371 | 1,207 | 807 |
| Retirement plan contributions | (24) | (45) | (19) |
| Changes in assets and liabilities, excluding effects of acquisitions, divestitures and foreign currency translation adjustments: | |||
| Receivables | 2 | 143 | (482) |
| Inventories | 105 | 31 | (72) |
| Prepayments and other current assets | 32 | (18) | (3) |
| Accounts payable and accrued expenses | (207) | (292) | 375 |
| Prepaid taxes and income taxes payable | (17) | (40) | (20) |
| Other assets and liabilities | 51 | (32) | 109 |
| Net cash provided by operating activities from continuing operations | $1,648 | $1,382 | $1,397 |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Cash paid during the year for: | |||
| Interest | $133 | $121 | $126 |
| Income taxes, net of refunds | $372 | $406 | $362 |
| Non-cash investing transactions: | |||
| Period end accounts payable related to property, plant and equipment purchases | $116 | $111 | $148 |
NOTE 26 DISCONTINUED OPERATIONS
The following table summarizes the financial results from discontinued operations of PHINIA. The Company did not report discontinued operations for the year ended December 31, 2025.
| (in millions) | ||
|---|---|---|
| 2024 | 2023 | |
| Net sales | $— | $1,723 |
| Cost of sales | — | 1,362 |
| Gross profit | — | 361 |
| Selling, general and administrative expenses | — | 173 |
| Restructuring expense | — | 7 |
| Other operating expense, net | 31 | 132 |
| Operating (loss) income | (31) | 49 |
| Equity in affiliates’ earnings, net of tax | — | (5) |
| Earnings from discontinued operations before income taxes | (31) | 54 |
| (Benefit) provision for income taxes | (2) | 61 |
| Net loss from discontinued operations attributable to PHINIA | $(29) | $(7) |
In connection with the Spin-Off, the Company entered into a transition services agreement through which the Company and PHINIA provided certain services to each other following the Spin-Off. These services were related to information technology, human resources, finance, facilities, procurement, sales, intellectual property and engineering. In December 2024, the Company and PHINIA executed an amendment to the original transition services agreement to extend certain engineering services until September 30, 2025. The transition services agreement expired and all related services ended on September 30, 2025. The combined impact of these services is reported in results of continuing operations in the Consolidated Financial Statements. During the year ended December 31, 2025, there wereno activities related to those services. During the year ended December 31, 2024 and 2023, the Company provided services at a cost of $7 million and $13 million to PHINIA, respectively, and PHINIA provided services at a cost of $2 million and $3 million to the Company, respectively.
The Company incurred $31 million and $132 million of costs relating to the Spin-Off during the year ended December 31, 2024 and 2023, respectively, which are reflected within Net loss from discontinued operations in the Company’s Consolidated Statements of Operations. Spin-Off costs are primarily comprised of professional fees and costs to separate certain operational activities, including costs to separate information technology systems which substantially concluded as of December 31, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.